<?xml version="1.0"?>
<rdf:RDF xmlns="http://purl.obolibrary.org/obo/vo/dev/vaccine_adjuvant.owl#"
     xml:base="http://purl.obolibrary.org/obo/vo/dev/vaccine_adjuvant.owl"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#">
    <owl:Ontology rdf:about="http://purl.obolibrary.org/obo/vo/dev/vaccine_adjuvant.owl"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000115 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000116 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000116"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000117 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000117"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000118 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000118"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000119 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000119"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000233 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000233"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005328 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/VO_0005328"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/RO_0000087 -->

    <owl:ObjectProperty rdf:about="http://purl.obolibrary.org/obo/RO_0000087"/>
    


    <!-- http://purl.obolibrary.org/obo/RO_0001000 -->

    <owl:ObjectProperty rdf:about="http://purl.obolibrary.org/obo/RO_0001000"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005312 -->

    <owl:ObjectProperty rdf:about="http://purl.obolibrary.org/obo/VO_0005312"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005377 -->

    <owl:ObjectProperty rdf:about="http://purl.obolibrary.org/obo/VO_0005377"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/NCBITaxon_12264 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCBITaxon_12264"/>
    


    <!-- http://purl.obolibrary.org/obo/PR_000001155 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PR_000001155"/>
    


    <!-- http://purl.obolibrary.org/obo/PR_000011271 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PR_000011271"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000093 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000093">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that is formed as a mineral salt.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>mineral salt vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000118 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000118">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that contains microbial derived material.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>microbial derivative vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000127 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000127">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000884"/>
        <obo:IAO_0000115>An aluminum vaccine adjuvant that contains aluminum hydroxide.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>alum</obo:IAO_0000118>
        <rdfs:label>aluminum hydroxide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000128 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000128">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000884"/>
        <obo:IAO_0000115>An aluminum vaccine adjuvant that is aluminum phosphate.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Adju-Phos®</obo:IAO_0000118>
        <obo:IAO_0000118>Al(PO)4</obo:IAO_0000118>
        <rdfs:label>aluminum phosphate vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000131 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000131">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000093"/>
        <obo:IAO_0000115>A mineral salt vaccine adjuvant composed of calcium phosphate.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>CaHPO4</obo:IAO_0000118>
        <rdfs:label>calcium phosphate vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000133 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000133">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that consists of a water-in-oil emulsion of aqueous antigen in paraffin (mineral) oil of low specific gravity and low viscosity. It is named after Jules T. Freund (1890-1960), Hungarian-born American immunologist. It is a water in oil emulsion.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>Freund&apos;s emulsified oil adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000139 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000139">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000133"/>
        <obo:IAO_0000115>A Freund&apos;s emulsified oil adjuvant that contains inactivated and dried mycobacteria, usually Mycobacterium tuberculosis (the pathogenic agent of tuberculosis).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <rdfs:label>complete Freund&apos;s adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000142 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000142">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000133"/>
        <obo:IAO_0000115>A Freund&apos;s emulsified oil adjuvant that does not contain the mycobacterial components.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <rdfs:label>incomplete Freund&apos;s adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000143 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000143">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant consisting of cholera toxin (CT) from Vibrio cholerae.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>CT</obo:IAO_0000118>
        <obo:IAO_0000118>cholera toxin</obo:IAO_0000118>
        <rdfs:label>cholera toxin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000146 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000146">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant that is the P40 particulate fraction isolated from Corynebacterium.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:8447157</obo:IAO_0000119>
        <rdfs:label>Corynebacterium-derived P40 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000147 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000147"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000179 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000179"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000181 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000181">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant made from bacterial lipopolysaccharide (LPS) of gram-negative bacteria.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>LPS vaccine adjuvant</obo:IAO_0000118>
        <rdfs:label>lipopolysaccharide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000187 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000187">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant formulated to correspond to a component found in a water-soluble extract of cell walls of mycobacteria used in complete Freund&apos;s adjuvant (CFA).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>MDP</obo:IAO_0000118>
        <obo:IAO_0000118>muramyl dipeptide</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:344799</obo:IAO_0000119>
        <rdfs:label>muramyl dipeptide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000190 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000190">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that contains an organic polymer with some antigenic epitopes which might be shared with other organic polymers acting as immunostimulators.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>squalene</obo:IAO_0000118>
        <rdfs:label>squalene vacccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000191 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000191">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is an emulsifier called Arlacel A.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>arlacel A</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:2042393</obo:IAO_0000119>
        <rdfs:label>arlacel A vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000192 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000192">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A Montanide vaccine adjuvant that is Montanide 103.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>Montanide 103</obo:IAO_0000118>
        <rdfs:label>Montanide 103 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000193 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000193">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivitive vaccine adjuvant that contains components from killed Bordetella pertussis. The killed B. pertussis has a strong adjuvant effect on the diphtheria and tetanus toxoids in the DPT vaccines.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <rdfs:label>Bordetella pertussis component vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000351 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000351">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is PCPP salt.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Adjumer</obo:IAO_0000118>
        <obo:IAO_0000118>PCPP salt</obo:IAO_0000118>
        <obo:IAO_0000118>polyidi (carboxylatophenoxy) lphosphazene</obo:IAO_0000118>
        <obo:IAO_0000118>polyphosphazene</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:75551218</obo:IAO_0000119>
        <rdfs:label>Adjumer vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000366 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000366">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001356"/>
        <obo:IAO_0000115>A particulate antigen delivery system vaccine adjuvant that contains particles made up of concentric lipid membranes containing phospholipids and other lipids in a bilayer configuration separated by aqueous compartments. It is a relatively stable but non-covalently-bound complex of saponin adjuvant Quil-A, cholesterol and amphipathic antigen in a molar ratio of approximately 1:1:1. The spectrum of viral capsid antigens and non-viral amphipathic antigens of relevance for human vaccination, incorporated into ISCOMs, comprises influenza, measles, rabies, gp340 from EB-virus, gp120 from HIV, Plasmodium falciparum and Trypanosoma cruzi.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.vaccination.inoz.com/adjuvants.html</obo:IAO_0000119>
        <rdfs:label>liposome-based vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000384 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000384">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001342"/>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:18472194
</obo:IAO_0000119>
        <rdfs:label>IL-15 plasmid vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000388 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000388">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant that is derived from E. coli heat labile toxin LT.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>E. coli LT toxin derived vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000559 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000559">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant, adamantylamide dipeptide (AdDP) is the desmuramyl analog of MDP.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>AdDP</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:8375945</obo:IAO_0000119>
        <rdfs:label>adamantylamide dipeptide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000580 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000580">
        <owl:equivalentClass>
            <owl:Class>
                <owl:intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/VO_0000179"/>
                    <owl:Restriction>
                        <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                        <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0000147"/>
                    </owl:Restriction>
                </owl:intersectionOf>
            </owl:Class>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000179"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0000147"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine component that is chemical substance added to vaccine and enhance and direct immune response to protective antigen. Many of vaccine adjuvants cause a range of serious side-effects.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <rdfs:label>vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000757 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000757">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001356"/>
        <obo:IAO_0000115>A particulate antigen delivery system vaccine adjuvant that consists of an assembly of antigens in multimeric form and presents an antigen to induce specific immunologic responses. The assembly is attached to a matrix with a built-in adjuvant, saponin. ISCOMs induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines. MeSH term: D20.215.894.860.449.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>ISCOM</obo:IAO_0000118>
        <obo:IAO_0000118>The immunostimulating complex</obo:IAO_0000118>
        <rdfs:label>ISCOM vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000884 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000884">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000093"/>
        <obo:IAO_0000115>A mineral salt vaccine adjuvant that is composed of some aluminum compound.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <rdfs:label>aluminum vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0000938 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0000938">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is derived from Xanthomonas campestris, has a pentasaccharide repeating unit structure, and its terminus contains a mannose moiety which acts as a toll-like receptor 2 agonist.</obo:IAO_0000115>
        <obo:IAO_0000117>Asiyah Yu Lin</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:19608270</obo:IAO_0000119>
        <obo:IAO_0000119>http://www.sciencedirect.com/science/article/pii/S0142961209006371</obo:IAO_0000119>
        <rdfs:label>xanthan gum vaccine ajuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001147 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001147">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that contains IL-12.</obo:IAO_0000115>
        <obo:IAO_0000117>Allen Xiang</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <rdfs:label>IL-12 vacince adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001237 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001237">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant compsed of CpG DNA.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:12899580</obo:IAO_0000119>
        <rdfs:label>CpG DNA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001238 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001238">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that is a stable oil-in-water emulsion.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&amp;N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&amp;N4=M6661%7CSIGMA&amp;N25=0&amp;QS=ON&amp;F=SPEC</obo:IAO_0000119>
        <rdfs:label>Ribi vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001239 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001239">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant named RC529 that is a lipid A mimetic.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:16204643</obo:IAO_0000119>
        <rdfs:label>RC529 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001240 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001240">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000884"/>
        <obo:IAO_0000115>An aluminum vaccine adjuvant that is aluminum potassium sulfate (AlK(SO4)2).</obo:IAO_0000115>
        <obo:IAO_0000117>Allen Xiang</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>aluminum potassium sulfate adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001241 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001241">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000127"/>
        <obo:IAO_0000115>An aluminum hydroxide vaccine adjuvant that is a gel that is made by precipitation of aluminum hydroxide Al(OH)3 under alkaline conditions.</obo:IAO_0000115>
        <obo:IAO_0000117>Allen Xiang</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Alhydrogel</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Alhydrogel vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001242 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001242">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001348"/>
        <obo:IAO_0000115>A cholera toxin derived vaccine adjuvant made of the B subunit of the cholera toxin from Vibrio cholerae.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>CTB</obo:IAO_0000118>
        <obo:IAO_0000118>cholera toxin B</obo:IAO_0000118>
        <rdfs:label>cholera toxin B subunit vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001249 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001249">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001239"/>
        <obo:IAO_0000115>An aqueous formula of the synthetic vaccine adjuvant RC529.</obo:IAO_0000115>
        <obo:IAO_0000116>RC529-AF can be obtained from Corixa Corporation (Seattle, WA).</obo:IAO_0000116>
        <obo:IAO_0000118>RC529 vaccine adjuvant in an aqueour formulation</obo:IAO_0000118>
        <obo:IAO_0000119>PMID: 15308371</obo:IAO_0000119>
        <rdfs:label>RC529-AF vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001250 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001250">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant derived from the lipopolysaccharide (LPS) of Salmonella minnesota R595.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>3-O-deacylated monophosphoryl lipid A vaccine adjuvant</obo:IAO_0000118>
        <obo:IAO_0000118>3D-MLA</obo:IAO_0000118>
        <obo:IAO_0000118>MPL vaccine adjuvant</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.frontiersin.org/articles/10.3389/fimmu.2020.577823</obo:IAO_0000119>
        <rdfs:label>monophosphoryl lipid A vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>PMID:10768940</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001251 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001251">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000388"/>
        <obo:IAO_0000115>An E. coli LT toxin derived vaccine adjuvant that is a mutant form of LT containing a Ser-Lys substitution in position 63 which has been shown to be totally devoid of toxicity stable to protease treatment and able to act as mucosal adjuvant.</obo:IAO_0000115>
        <obo:IAO_0000116>LTK63 is an enzymatically inactive mutant of the heat-labile enterotoxin of Escherichia coli. It can be used as a potent mucosal adjuvant.</obo:IAO_0000116>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:9607006</obo:IAO_0000119>
        <rdfs:label>LTK63 vaccine mutant</rdfs:label>
        <rdfs:seeAlso>PMID:10790422</rdfs:seeAlso>
        <rdfs:seeAlso>PMID:17920733</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001259 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001259">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant derived from heat-killed Corynebacterium parvum.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:5483667</obo:IAO_0000119>
        <rdfs:label>killed Corynebacterium parvum vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>PMID:4596278</rdfs:seeAlso>
        <rdfs:seeAlso>PMID:7591056</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001260 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001260">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant which is a water-in-oil adjuvant with CRL-8300 (a block copolymer), squalene, and sorbitan monooleate.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Titermax Gold</obo:IAO_0000118>
        <rdfs:label>Titermax Gold vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>URL: http://www.titermax.com/i_gold4.htm</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001261 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001261">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is dimethyldioctadecylammonium bromide (DDA), a lipophilic quaternary ammonium salt known as a good adjuvant when co-administered systemically or nasally with an antigen.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Dimethyl dioctadecyl ammonium bromide</obo:IAO_0000118>
        <rdfs:label>DDA vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>PMID:1439129</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001262 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001262">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000366"/>
        <obo:IAO_0000115>A liposome-based vaccine adjuvant that have a positive surface charge.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>cationic liposomal vaccine adjuvant DDA:TDB</rdfs:label>
        <rdfs:seeAlso>PMID:19874860</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001263 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001263">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001358"/>
        <obo:IAO_0000115>A tenosactive compound vaccine adjuvant that contains purified extract from the bark of the South American tree Quillaja saponaria Molina.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>QuilA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001264 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001264">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant comprised of monophosphoryl lipid A (MPL), QS21 and an oil in water emulsion.</obo:IAO_0000115>
        <obo:IAO_0000116>monophosphoryl lipid A (MPL), QS21 and an oil in water emulsion.</obo:IAO_0000116>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>AS02 vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>PMID:15187142</rdfs:seeAlso>
        <rdfs:seeAlso>PMID:15780441</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001265 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001265">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant that is a combination of 50 Œºg of the immunoenhancer MPL (3-O-desacyl-4‚Ä≤-monophosphoryl lipid A) with 500 Œºg of aluminium salt.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:21527299</obo:IAO_0000119>
        <rdfs:label>AS04 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001266 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001266">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant which is an emulsion plus DDA.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Emulsigen D</obo:IAO_0000118>
        <obo:IAO_0000118>VSA-3</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:16187717</obo:IAO_0000119>
        <rdfs:label>VSA-3 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001267 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001267">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001358"/>
        <obo:IAO_0000115>A tensoactive compound vaccine adjuvant that is derived from saponin, a compound that is an immunostimulator found in the plant P. senega.</obo:IAO_0000115>
        <rdfs:label>saponin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001268 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001268">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A Montanide vaccine adjuvant that is formulated as water-in-oil emulsions and induces high antibody titers in several animal species. It is a vaccine adjuvant composed of metabolizable oil and a surfactant system designed to make a water-in-oil emulsion. It has been used since 1992 in more than 50 clinical trials related to therapeutic vaccines against various diseases such as cancer and malaria.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Montanide ISA 720</obo:IAO_0000118>
        <obo:IAO_0000118>Montanide ISA 720 VG</obo:IAO_0000118>
        <obo:IAO_0000119>WEB: http://www.seppic.com/human-health/vaccine-adjuvant/montanide-isa-720-@/view-1044-seproduit.html?menuid=,979,&amp;lang=en</obo:IAO_0000119>
        <rdfs:label>Montanide ISA 720 vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>PMID:15752840</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001269 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001269">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A Montanide vaccine adjuvant that is a mineral oil adjuvant.</obo:IAO_0000115>
        <rdfs:label>Montanide incomplete Seppic adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001270 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001270">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A Montanide vaccine adjuvant that is a vaccine adjuvant composed of a light mineral oil and a surfactant system designed to make a water-in-oil emulsion.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Montanide ISA51</obo:IAO_0000118>
        <obo:IAO_0000119>WEB: http://www.seppic.com/human-health/vaccine-adjuvant/montanide-isa-51-@/view-1042-seproduit.html?menuid=,979,&amp;lang=en</obo:IAO_0000119>
        <rdfs:label>Montanide ISA51 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001271 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001271">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant developed by Montanide.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.montanide.com/</obo:IAO_0000119>
        <rdfs:label>Montanide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001272 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001272">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000388"/>
        <obo:IAO_0000115>An E. coli LT toxin derived vaccine adjuvant composed of the B subunit of E. coli heat-labile toxin.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>B subunit of E. coli heat-labile enterotoxin</obo:IAO_0000118>
        <rdfs:label>EtxB vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001273 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001273">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant with the tradename Polygen.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>Polygen vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>URL: http://www.mvp-technologies.com/adjuvants/Polygen%20Final%20Technical%20Bulletin.pdf</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001285 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001285">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <obo:IAO_0000115>A carbohydrate vaccine adjuvant, which enhances both humoral and cell-mediated immunity to oligopeptides in experimental animal models.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Algal Glucan vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001286 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001286">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant that suspension of 1-2≈í¬∫m ovoids of immune stimulant gamma inulin (g-IN) in which alum is embedded as a carrier for protein or other anionic antigens.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:1887671</obo:IAO_0000119>
        <rdfs:label>Algammulin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001287 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001287">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is Bay R1005 (N-(2-Deoxy-2-L-leucylamino Œ≤-D-glucopyranosyl)-N-octadecyldodecanoylamide hydroacetate ).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>BAY R1005</obo:IAO_0000118>
        <obo:IAO_0000118>N-( 2-Deoxy-2-L-leucylamino-β-D-glucopyranosyl)-N-octadecyldodecanoylamide hydroacetate</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>BAY R1005 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001288 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001288">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is N, N-dioctadecyl-N‚Ä≤, N‚Ä≤-bis( 2-hydroxyethyl) propanediamine (Avridine).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Avridine</obo:IAO_0000118>
        <obo:IAO_0000118>CP20,96</obo:IAO_0000118>
        <obo:IAO_0000118>N, N-dioctadecyl-N&apos;, N&apos;-bis( 2-hydroxyethyl) propanediamine</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Avridine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001289 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001289">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000131"/>
        <obo:IAO_0000115>A calcium phosphate vaccine adjuvant that is a gel prepared by precipitating soluable calcium and phosphate salts.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>calcium phosphate gel</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>calcium phosphate gel vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001290 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001290">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant composed of the CTA1-DD fusion protein.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>CTA1-DD gene fusion protein</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>cholera toxin A1-subunit-ProteinA D-fragment fusion protein</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001291 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001291">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000093"/>
        <obo:IAO_0000115>A mineral salt vaccine adjuvant that is composed of Deoxycholic acid sodium salt (DOC) complexed with aluminum hydroxide.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>DOC/Alum Complex</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>DOC/Alum Complex vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001292 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001292">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <obo:IAO_0000115>A carbohydrate adjuvant that is a highly specific activator of the alternative pathway of complement in vitro and in vivo, and is composed of linear (unbranched) b-D-(2-1) polyfructofuranosyl-a-D-glucose.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:3265692</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>gamma Inulin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001293 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001293">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant that is comprised of a mixture of GMDP, DDA, and Zinc L-proline salt complex (ZnPro8).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:15953835</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Gerbu vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001294 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001294">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that includes GM-CSF.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>GM-CSF vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001295 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001295">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant containing GMDP, a higly effective primary adjuvant.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>GMDP</obo:IAO_0000118>
        <obo:IAO_0000118>N-acetylglucosaminyl-(b1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>GMDP vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001296 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001296">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001360"/>
        <obo:IAO_0000115>An IFN-gamma vaccine adjuvant that is composed of recombinant hIFN-gamma.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>recombinant hIFN-gamma/Interferon-g vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001297 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001297">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that includes IL-1b.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>interleukin-1b vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001298 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001298">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that includes IL-2.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>IL-2 vaccine adjuvant</obo:IAO_0000118>
        <rdfs:label>interleukin-2 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001299 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001299">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that includes IL-7.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>IL-7 vaccine adjuvant</obo:IAO_0000118>
        <rdfs:label>interleukin-7 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001300 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001300">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that includes loxoribine which is a guanosine analog derivatized at position N7 and C8, and activates TLR-7.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>7-allyl-8-oxoguanosine</obo:IAO_0000118>
        <obo:IAO_0000118>Loxoribine</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Loxoribine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001301 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001301">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant consisting of an oil (squalene)-in-water nano emulsion.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>MF59</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:20488726</obo:IAO_0000119>
        <rdfs:label>MF59 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001302 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001302">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000366"/>
        <obo:IAO_0000115>A liposome-based vaccine adjuvant that consists of liposomes containing  the synthetic lipophilic analog of muramyl dipeptide, muramyl tripeptide phosphatidylethanolamine (MTP-PE).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>MTP-PE</obo:IAO_0000118>
        <obo:IAO_0000118>MTP-PE Liposomes</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:1431559</obo:IAO_0000119>
        <rdfs:label>MTP-PE Liposomes vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001303 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001303">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant made of murametide that has adjuvant activity similar to MDP.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Murametide</obo:IAO_0000118>
        <obo:IAO_0000118>Nac-Mur-L-Ala-D-Gln-OCH3</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Murametide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001304 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001304">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant called murapalmitine.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Murapalmitine</obo:IAO_0000118>
        <obo:IAO_0000118>Nac-Mur-L-Thr-D-isoGIn-sn-glyceroI dipalmitoyl</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Murapalmitine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001305 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001305">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that includes an MDP analog called D-Murapalmitine.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>D-Murapalmitine</obo:IAO_0000118>
        <obo:IAO_0000118>Nac-Mur-D-Ala-D-isoGln-sn-glycerol dipalmitoyl</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>D-Murapalmitine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001306 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001306">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is composed of neuraminidase-galactose oxidase (NAGO) a mixture of mixture of the two enzymes-neuraminidase and galactose oxidase.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>NAGO</obo:IAO_0000118>
        <obo:IAO_0000118>Neuraminidase-galactose oxidase</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>NAGO vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001307 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001307">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant consisting of multi-lamellar vesicles comprising a mixture of non-ionic surfactant (e.g., 1-monopalmitoyl-rac-glycerol), cholesterol and dicetyl phosphate used as a primary vaccine adjuvant for entrapped antigen.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>NISV</obo:IAO_0000118>
        <obo:IAO_0000118>non-ionic surfactant vesicles</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>non-ionic surfactant vesicles vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001308 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001308">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant made from the emulsion polymerization of methyl methacrylate.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>PMMA</obo:IAO_0000118>
        <obo:IAO_0000118>Polymethyl methacrylate</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>PMMA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001309 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001309">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant synthesized from stable protein phospholipid-calcium precipitates.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>protein cochleates</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>protein cochleates vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001310 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001310">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001267"/>
        <obo:IAO_0000115>A saponin vaccine adjuvant that is composed of extracts from the bark of the Quillaja saponaria Molina tree. Specifically, it is an acylated 3, 28-bisdesmodic triterpene glycosides (1,3) or ‚Äö√Ñ√∂‚àö√ë‚àö‚à´saponin‚Äö√Ñ√∂‚àö√ë‚àöœÄ with a molecular formula of C92O46H148 and molecular weight of 1990 Da. QS-21 is one of the active fractions of the bark of Chilean tree, Quillaja saponaria, purified using a reverse-phase chromatography (RP-HPLC).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>QS-21</obo:IAO_0000118>
        <obo:IAO_0000118>Stimulon™ QS-21 Adjuvant</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:27213168</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>QS-21 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001311 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001311">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000884"/>
        <obo:IAO_0000115>An aluminum vaccine adjuvant that is a synthetic oxyhydroxide of aluminum (aluminum hydroxide) prepared by acid-base precipitation.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Rehydragel HPA</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Rehydragel HPA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001312 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001312">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000127"/>
        <obo:IAO_0000115>An aluminum hydroxide vaccine adjuvant that is a low visosity aluminum hydroxide gel.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Rehydragel LV</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Rehydragel LV vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001313 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001313">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that contains the 163-171 peptide of IL-1β.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>IL-1β 163-171 peptide vaccine adjuvant</obo:IAO_0000118>
        <obo:IAO_0000118>Sclavo peptide</obo:IAO_0000118>
        <rdfs:label>Sclavo peptide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001314 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001314">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that is a water-in-oil emulsion that is used as an adjuvant and has immunostimulating properties similar to Freund&apos;s complete adjuvant (FCA).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Specol</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:1439130</obo:IAO_0000119>
        <rdfs:label>Specol vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001315 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001315">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that is an emulsion of squalane (5%), Tween 80( 0.2%), Pluronic L121( 1.25%), phosphate-buffered saline pH 7.4, and antigen.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>SPT (Antigen Formulation)</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001316 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001316">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant stearyl tyrosine is considered an &quot;organic equivelant&quot; of aluminum hydroxide.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>stearyl tyrosine</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>stearyl tyrosine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001317 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001317">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant called Theramide that is composed of N-acetylglucosaminyl-N-acetylinuramyl-L-Ala-D-isoGlu-L-Ala-dipalmitoxy propylamide (DTP-DPP).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Theramide</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Theramide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001318 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001318">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is a copolymer (CRL1005), based on a 12 kDa polyoxypropylene (POP) core with 5% POE.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>CRL1005</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:10717336</obo:IAO_0000119>
        <rdfs:label>CRL1005 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001319 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001319">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant and is made from non-toxic lipid droplets a few hundred nanometers in diameter and made from surfactants approved for human consumption and common food substances that are &apos;Generally Recognized as Safe&apos; (GRAS) by the FDA.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>http://nano.med.umich.edu/platforms/Nanoemulsions.html</obo:IAO_0000119>
        <rdfs:label>nanoemulsion vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001320 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001320">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emusion vaccine adjuvant that contains ≈í¬±-tocopherol and squalene, two biodegradable polyprenyls, in an oil-in-water emulsion.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>AS03</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:21256188</obo:IAO_0000119>
        <rdfs:label>AS03 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001321 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001321">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000388"/>
        <obo:IAO_0000115>An E. coli LT toxin derived vaccine adjuvant that is a mutant form of E.coli heat-labile toxin.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>LTR192G</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:11803061</obo:IAO_0000119>
        <rdfs:label>LTR192G vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001322 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001322">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant containing E. coli heat-labile toxin.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>E. coli heat-labile toxin, LT</obo:IAO_0000118>
        <obo:IAO_0000118>LT Oral Adjuvant</obo:IAO_0000118>
        <obo:IAO_0000118>LT-OA</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>E. coli heat-labile toxin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001323 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001323">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000884"/>
        <obo:IAO_0000115>An aluminum vaccine adjuvant that is a a proprietary aluminum hydroxyphosphate sulfate formulation that is both physically and functionally distinct from traditional aluminum phosphate and aluminum hydroxide adjuvants.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>AAHSA</obo:IAO_0000118>
        <obo:IAO_0000118>Merck Aluminum Adjuvant</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:17581283</obo:IAO_0000119>
        <rdfs:label>amorphous aluminum hydroxyphosphate sulfate adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001324 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001324">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001358"/>
        <obo:IAO_0000118>Matrix-S</obo:IAO_0000118>
        <rdfs:label>Matrix-S vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001328 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001328">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant contiaing imiquimod a imidazoquinoline.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>1-(2-methypropyl)-IH-imidazo[4,5-c]quinolin-4-amine</obo:IAO_0000118>
        <obo:IAO_0000118>Aldara™</obo:IAO_0000118>
        <obo:IAO_0000118>R-837</obo:IAO_0000118>
        <obo:IAO_0000118>S26308</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:18566444</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>imiquimod vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001329 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001329">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant, resiquimod is a chemical analog of imiquimod.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:15068862</obo:IAO_0000119>
        <rdfs:label>resiquimod vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001330 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001330">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant containing 2.5% squalene.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:20193791</obo:IAO_0000119>
        <rdfs:label>AF03 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001331 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001331">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant composed of flagellin from gram-negative bacteria.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>FliC</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:16428759</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:21048152</obo:IAO_0000119>
        <rdfs:label>Flagellin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001332 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001332">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant containing Poly(I:C), a synthetic double stranded analog of RNA.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>polyriboinosinic-polyribocytidylic acid</obo:IAO_0000118>
        <obo:IAO_0000119>WEB: http://en.wikipedia.org/wiki/Polyinosinic:polycytidylic_acid</obo:IAO_0000119>
        <rdfs:label>poly(I:C) vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001333 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001333">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001356"/>
        <obo:IAO_0000115>A particulate antigen delivery system vaccine adjuvant that is a vaccine adjuvant comprising cholesterol, phospholipid and saponin but without antigen.</obo:IAO_0000115>
        <obo:IAO_0000116>ISCOMATRIX is identical to ISCOMs except that it does not contain antigen. Ref: PMID: 17336431.</obo:IAO_0000116>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:19450632</obo:IAO_0000119>
        <rdfs:label>ISCOMATRIX vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001334 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001334">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001267"/>
        <obo:IAO_0000115>A saponin vaccine adjuvant that is made from highly purified saponins.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>WEB: http://www.isconova.com/products/abisco-research-reagent/abisco-100.aspx</obo:IAO_0000119>
        <rdfs:label>Abisco-100 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001335 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001335">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001356"/>
        <obo:IAO_0000115>A particulate antigen delivery system vaccine adjuvant  that is albumin-heparin microparticles vaccine adjuvant that is prepared from albumin and heparin stabilized by cross-linking reaction with EDC.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:16734558</obo:IAO_0000119>
        <rdfs:label>albumin-heparin microparticles vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001336 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001336">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant and is based on the combination of Monophosphoryl Lipid A(MPL), QS21 (a purified fraction of Saponin extracted from Quillarja Saponaria), and a proprietary oil in water emulsion.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.pasteur.fr/applications/euroconf/vaccins/vaccins-abs.html</obo:IAO_0000119>
        <rdfs:label>AS-2 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001337 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001337">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that includes B7-2.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>B7-2 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001338 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001338">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is a local anaesthetic drug belonging to the amino amide group, and is used as a vaccine adjuvant in DNA vaccines.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:15246629</obo:IAO_0000119>
        <obo:IAO_0000119>WEB: http://en.wikipedia.org/wiki/Bupivacaine</obo:IAO_0000119>
        <rdfs:label>Bupivacaine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001339 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001339">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000366"/>
        <obo:IAO_0000115>A liposome-based vaccine adjuvant that is composed of virus sized liposomes that contain a DNA plasmid.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>cationic liposome-DNA complex JVRS-100</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:19285425</obo:IAO_0000119>
        <rdfs:label>cationic liposome-DNA complex JVRS-100 vaccin adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001340 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001340">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is DHEA, which is relatively stable and can be directly incorporated into vaccine formulations.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>5-androsten-3β-ol-17-one</obo:IAO_0000118>
        <obo:IAO_0000118>DHA</obo:IAO_0000118>
        <obo:IAO_0000118>Dehydroepiandrosterone</obo:IAO_0000118>
        <obo:IAO_0000118>androstenolone</obo:IAO_0000118>
        <obo:IAO_0000118>prasterone</obo:IAO_0000118>
        <obo:IAO_0000118>transdehydroandrosterone</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>DHEA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001341 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001341">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is PLGA, which has been used in the controlled delivery of peptide drugs.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>PLGA</obo:IAO_0000118>
        <obo:IAO_0000118>PLGA microspheres</obo:IAO_0000118>
        <obo:IAO_0000118>Polyester poly (DL-lactide-co-glycolide)</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:15560948</obo:IAO_0000119>
        <rdfs:label>DL-PGL (Polyester poly (DL-lactide-co-glycolide)) vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001342 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001342">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that uses the adjuvant effect of cytokine IL-15.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>IL-15 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001343 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001343">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000366"/>
        <obo:IAO_0000115>A liposome-based vaccine adjuvant which is prepared from dehydration-rehydration vesicles (DRVs).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>immunoliposomes containing antibodies to costimulatory molecules</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001344 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001344">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000388"/>
        <obo:IAO_0000115>An E. coli LT toxin derived vaccine adjuvant that is a mutant form of heat-labile Escherichia coli enterotoxin (LT) that contains a substitution Ala ‚Äö√ú√≠ Arg in position 72 of the A subunit.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:9529328</obo:IAO_0000119>
        <rdfs:label>LTK72 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001345 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001345">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant containing MPL and squalene.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:12213399</obo:IAO_0000119>
        <rdfs:label>MPL-SE vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001347 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001347">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001348"/>
        <obo:IAO_0000115>A microbial derived vaccine adjuvant made of E112K mC,  a mutated CT created by substituting a single amino acid in the ADP-ribosyltransferase active centre, glutamate to lysine at position 112.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>mCT</obo:IAO_0000118>
        <obo:IAO_0000118>non-toxic mutant E112K of Cholera Toxin mCT-E112K</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:11251876</obo:IAO_0000119>
        <rdfs:label>non-toxic mutant E112K of Cholera Toxin mCT-E112K vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001348 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001348">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant that is derived from cholera toxin.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>cholera toxin derived vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001349 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001349">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant that is composed of threonyl-MDP (0.05-1%) in an emulsion vehicle [5% squalane, 2.5% Pluronic¬¨√Ü L121, 0.2% Polysorbate 80 and phosphate buffered saline (pH 7.4)].</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>SAF-1 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001350 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001350">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000366"/>
        <obo:IAO_0000115>A liposome-based vaccine adjuvant that includes the glycoproteins of Sendai virus.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>Sendai Proteoliposomes, Sendai-containing Lipid Matrices</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001351 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001351">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001357"/>
        <obo:IAO_0000115>A synthetic vaccine adjuvant that is threonyl muramyl dipeptide (TMDP).</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>N-acetyl muramyl-L-threonyl-D-isoglutamine</obo:IAO_0000118>
        <obo:IAO_0000118>Termurtide™</obo:IAO_0000118>
        <obo:IAO_0000118>[thr1 ]-MDP</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>threonyl muramyl dipeptide (TMDP) vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001352 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001352">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant made of virus like particles (VLPS) containing the yeast retrotransposon Ty which has the amino acids 1-381 of the pI protein encoded.</obo:IAO_0000115>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>Ty-VLPs</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:7551218</obo:IAO_0000119>
        <rdfs:label>ty particles vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001353 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001353">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that contains active cytokine compound.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>cytokine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001354 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001354">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that is composed of differnt compounds under more than one category.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>combination vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001355 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001355">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:label>emulsion vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001356 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001356">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that serves as a particulate antigen delivery system.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>particulate antigen delivery system vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001357 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001357">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that contains synthetic material.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Philip Huang</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>synthetic vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001358 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001358">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that includes tensioactive material. Tensioactive materials, surfactants or active surface agents are chemical substances with a polar-non polar structure. These substances have a tendency to locate themselves at the surface creating an adsorbed monomolecular layer on the interface.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <obo:IAO_0000118>tensioactive compound vaccine adjuvant</obo:IAO_0000118>
        <obo:IAO_0000119>WEB: http://www.citt.ufl.edu/team/sepulveda/html/en_tensioactivos.htm</obo:IAO_0000119>
        <rdfs:label>tensoactive compound vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001359 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001359">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that is primarily composed of carbohydrates.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>carbohydrate vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0001360 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0001360">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001353"/>
        <obo:IAO_0000115>A cytokine vaccine adjuvant that includes IFN-gamma.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Samantha G. Sayers</obo:IAO_0000117>
        <rdfs:label>IFN-gamma vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0003154 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0003154">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001237"/>
        <obo:IAO_0000115>A CpG DNA vaccine adjuvant that is a short, synthetic, unmethylated CpG oligodeoxynucleotide (CpG ODN) with immunostimulatory activity.</obo:IAO_0000115>
        <obo:IAO_0000116>ISS 1018 is a short, synthetic, unmethylated CpG oligodeoxynucleotide (CpG ODN) with immunostimulatory activity. ISS 1018 signals through Toll-like receptor 9 (TLR9) to induce the production of immunoglobulin by B cells and interferon (IFN) -alpha, IFN-beta, interleukin-12 (IL-12), and tumor necrosis factor - alpha (TNF-alpha) by plasmacytoid dendritic cells (pDC). ISS 1018 CpG ODN promotes antigen presentation and co-stimulatory molecule expression. ISS 1018 is currently being investigated in combination with HBsAg vaccine as a prophylactic treatment for to prevent Hepatitis B in adults. It is also being investigated in combination with rituximab for treatment of b-cell or non-hodgkin&apos;s lymphoma.</obo:IAO_0000116>
        <obo:IAO_0000117>Kallan Roan</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000118>ISS 1018 CpG ODN</obo:IAO_0000118>
        <obo:IAO_0000118>ISS 1018 CpG oligodeoxynucleotide</obo:IAO_0000118>
        <obo:IAO_0000118>ISS-1018</obo:IAO_0000118>
        <obo:IAO_0000119>https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iss-1018-cpg-oligodeoxynucleotide</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.drugbank.ca/drugs/DB05463</obo:IAO_0000119>
        <rdfs:label>ISS 1018 CpG ODN vaccine adjuvant</rdfs:label>
        <rdfs:seeAlso>DrugBank Accession number: DB05463</rdfs:seeAlso>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005206 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005206">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001267"/>
        <obo:IAO_0000115>A saponin vaccine adjuvant comprised of 40 nm nanoparticles composed of Quillaja saponins, cholesterol and phospholipid.</obo:IAO_0000115>
        <obo:IAO_0000117>Philip Huang</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:22844480</obo:IAO_0000119>
        <rdfs:label>Matrix-M vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005207 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005207">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A carbohydrate vaccine adjuvant derived from delta inulin</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Carbohydrate
Mechanism of Action: Complement, Dendritic cells (unknown receptor), Other, Unknown
Immune profile induced: mixed Th1/Th2
By routes: IM, IN, IP, SQ, inhalation,
Point of Contact: Nikolai Petrovsky, Vaxine
https://www.ncbi.nlm.nih.gov/pubmed/?term=31009889
https://www.ncbi.nlm.nih.gov/pubmed/?term=25520500
https://www.ncbi.nlm.nih.gov/pubmed/?term=28758637
https://www.ncbi.nlm.nih.gov/pubmed/?term=23864620
https://www.ncbi.nlm.nih.gov/pubmed/?term=24342245
https://www.ncbi.nlm.nih.gov/pubmed/?term=23306367
https://www.ncbi.nlm.nih.gov/pubmed/?term=21147758
https://www.ncbi.nlm.nih.gov/pubmed/?term=15479440
https://www.ncbi.nlm.nih.gov/pubmed/?term=26031451
https://www.ncbi.nlm.nih.gov/pubmed/?term=25659269
https://www.ncbi.nlm.nih.gov/pubmed/?term=33883559
https://www.ncbi.nlm.nih.gov/pubmed/?term=30312742
https://www.ncbi.nlm.nih.gov/pubmed/?term=21736913
https://www.ncbi.nlm.nih.gov/pubmed/?term=30218687
https://www.ncbi.nlm.nih.gov/pubmed/?term=25459531
https://www.ncbi.nlm.nih.gov/pubmed/?term=24958701
https://www.ncbi.nlm.nih.gov/pubmed/?term=25516480
https://www.ncbi.nlm.nih.gov/pubmed/?term=20130134
https://www.ncbi.nlm.nih.gov/pubmed/?term=23388724
https://www.ncbi.nlm.nih.gov/pubmed/?term=21169215
https://www.ncbi.nlm.nih.gov/pubmed/?term=30832356
https://www.ncbi.nlm.nih.gov/pubmed/?term=30322015
https://www.ncbi.nlm.nih.gov/pubmed/?term=28602608
https://www.ncbi.nlm.nih.gov/pubmed/?term=28676380
https://www.ncbi.nlm.nih.gov/pubmed/?term=33542494
https://www.ncbi.nlm.nih.gov/pubmed/?term=26232344
https://www.ncbi.nlm.nih.gov/pubmed/?term=22728225
https://www.ncbi.nlm.nih.gov/pubmed/?term=22728225
https://www.ncbi.nlm.nih.gov/pubmed/?term=25267153
https://www.ncbi.nlm.nih.gov/pubmed/?term=31300280
https://www.ncbi.nlm.nih.gov/pubmed/?term=28301280
https://www.ncbi.nlm.nih.gov/pubmed/?term=22717330
https://www.ncbi.nlm.nih.gov/pubmed/?term=26177480
https://www.ncbi.nlm.nih.gov/pubmed/?term=10000000
https://www.ncbi.nlm.nih.gov/pubmed/?term=27342914
https://www.ncbi.nlm.nih.gov/pubmed/?term=12</obo:IAO_0000116>
        <obo:IAO_0000117>Nikolai Petrovsky</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Philip Huang</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:22728225</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=37</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=10000000</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=12</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=15479440</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=20130134</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21147758</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21169215</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21736913</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=22717330</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=22728225</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=23306367</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=23388724</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=23864620</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24342245</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24958701</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25267153</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25459531</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25516480</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25520500</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25659269</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26031451</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26177480</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26232344</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=27342914</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28301280</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28602608</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28676380</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28758637</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30218687</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30312742</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30322015</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30832356</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31009889</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31300280</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33542494</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33883559</obo:IAO_0000119>
        <obo:VO_0005328>37</obo:VO_0005328>
        <rdfs:label>Advax vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005270 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005270">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes IV270, which is a low‚Äìmolecular weight TLR7 agonist conjugated to a phospholipid and is a highly potent and stable immune activator.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: TLR7
Mechanism of Action: Activation of innate immune pathways
Immune profile induced: Th1-biased
Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Induces epitope spreading, (4) Provides innate protection, (5) Promotes antibody affinity maturation, (6) Promotes antibody epitope spreading By routes: intramuscular and intranasal.
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>1V270</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:25568203</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:28724768</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:32636840/</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=6</obo:IAO_0000119>
        <obo:VO_0005328>6</obo:VO_0005328>
        <rdfs:label>1V270 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005271 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005271">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: TLR4
Mechanism of Action: Innate immune activation
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: (1) Induces mucosal immunity, (2) Anti-inflammatory, (3) Promotes antibody epitope spreading. By routes: intramuscular and intranasal.
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>2B182C</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=7</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25568203</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28724768</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32636840</obo:IAO_0000119>
        <obo:VO_0005328>7</obo:VO_0005328>
        <rdfs:label>2B182C vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005272 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005272"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005281 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005281">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: Dendritic cells (unknown receptor)
Mechanism of Action: Innate immune activation
Immune profile induced: Th1-biased
Other Features/Characteristics: Other. Specify: Co-adjuvant for TLR4 ligands
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>2E151</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=9</obo:IAO_0000119>
        <obo:VO_0005328>9</obo:VO_0005328>
        <rdfs:label>2E151 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005282 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005282">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005313"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: CLR (Dectin, Mincle)
Mechanism of Action: None/Unknown
Immune profile induced: Th17-component
Other Features/Characteristics: None
Point of Contact: Kendal Ryter, U. Montana &amp; Inimmune</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Kendal Ryter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>UM-1098</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=27</obo:IAO_0000119>
        <rdfs:label>UM-1098 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005283 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005283">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule and Synthetic derivative of natural compound
Receptor: Unknown and NLRP3
Mechanism of Action: Presumably the same as QS-21 in the absence of dose-limiting toxicity
Immune profile induced: Th1-biased
Other Features/Characteristics: None
Point of Contact: Melissa Malhame, Adjuvance Technologies</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Melissa Malhame</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>TQL-1055</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=36</obo:IAO_0000119>
        <rdfs:label>TQL-1055 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005284 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005284">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005307"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005314"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Emulsion
Receptor: TLR2 and TLR4
Mechanism of Action: Activation of mucosal and systemic immunity
Immune profile induced: Th1/Th17
Other Features/Characteristics: Promotes antibody affinity maturation
Point of Contact: Ali Fattom, BlueWillow Biologics</obo:IAO_0000116>
        <obo:IAO_0000117>Ali Fattom</obo:IAO_0000117>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>NanoVax/NE01</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=22</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31495593</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31515143</obo:IAO_0000119>
        <rdfs:label>NanoVax/NE01 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005285 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005285">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Other
Receptor: TLR4
Mechanism of Action: TLR4 agonist
Immune profile induced: Th1-biased
Other Features/Characteristics: None/Unknown
Point of Contact: Darrick Carter, PAI Life Sciences</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Darrick Carter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>MiT4</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=16</obo:IAO_0000119>
        <rdfs:label>MiT4 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005286 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005286">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) Natural compound, (2) Carbohydrate, (3) Combination adjuvant
Receptor: CLR (Dectin, Mincle) and NAIP
Mechanism of Action: Activation of Dectin-2-expressing innate immune cells; dual targeting of injection site and draining lymph node.
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: Promotes antibody epitope spreading
Point of Contact: Ivan Zanoni, Boston Children&apos;s Hospital</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Ivan Zanoni</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=14</obo:IAO_0000119>
        <rdfs:label>Mannadjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005287 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005287">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Combination Adjuvant
Receptor: TLR4
Mechanism of Action: TLR4 agonist plus potential inflammasome
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None/Unknown
Point of Contact: Darrick Carter, PAI Life Sciences</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Darrick Carter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>LiT4</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=20</obo:IAO_0000119>
        <rdfs:label>LiT4 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005288 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005288">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005306"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: TLR7 and TLR8
Mechanism of Action: None/Unknown
Immune profile induced: Th1-biased
Other Features/Characteristics: None
Point of Contact: Kendal Ryter, U. Montana &amp; Inimmune</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Kendal Ryter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>INI-4001</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=28</obo:IAO_0000119>
        <rdfs:label>INI-4001 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005289 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005289">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: TLR4
Mechanism of Action: None/Unknown
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Kendal Ryter, U. Montana &amp; Inimmune</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Kendal Ryter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>INI-2004</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=26</obo:IAO_0000119>
        <rdfs:label>INI-2004 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005290 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005290">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: TLR4
Mechanism of Action: None/Unknown
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Kendal Ryter, U. Montana &amp; Inimmune</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Kendal Ryter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>INI-2002</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=29</obo:IAO_0000119>
        <rdfs:label>INI-2002 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005291 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005291">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule and Combination adjuvant
Receptor: TLR4 and TLR7
Mechanism of Action: Activation of antigen presenting cells and stimulating B cell proliferation
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Induces epitope spreading, (4) Provides innate protection, (5) Promotes antibody epitope spreading. By routes: intramuscular and intranasal.
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Fos47</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=5</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25568203</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28724768</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32636840</obo:IAO_0000119>
        <rdfs:label>Fos47 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005292 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005292">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Emulsion
Receptor: TLR4
Mechanism of Action: Squalene emulsion plus TLR4
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Darrick Carter, PAI Life Sciences</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Darrick Carter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>EmT4</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=17</obo:IAO_0000119>
        <rdfs:label>EmT4 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005293 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005293">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000116>Chemical Nature: Emulsion
Receptor: Unknown
Mechanism of Action: Squalene emulsion possibly triggering inflammasome or through extracellular ATP
Immune profile induced: None
Other Features/Characteristics: None
Point of Contact: Darrick Carter, PAI Life Sciences</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Darrick Carter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Em</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=18</obo:IAO_0000119>
        <rdfs:label>Em vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005294 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005294">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0006102"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005305"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) Synthetic derivative of natural compound, (2) Nucleic acid
Receptor: TLR3
Mechanism of Action: TLR3, possibly RIG-I - agonist
Immune profile induced: Th1-biased
Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Provides innate protection. By routes: SQ, IM.
Point of Contact: Carolina Lopez, University of Washington at St Louis</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Carolina Lopez</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>DDO</obo:IAO_0000118>
        <obo:IAO_0000118>DDO (Defective viral genome-Derived Oligonucleotide)</obo:IAO_0000118>
        <obo:IAO_0000118>Defective viral genome-Derived Oligonucleotide</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=30</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24099876</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29861183</obo:IAO_0000119>
        <rdfs:label>defective viral genome-derived oligonucleotide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005295 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005295">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Synthetic derivative of natural compound
Receptor: Unknown
Mechanism of Action: (1) Antigen carrier, (2) Innate immune enhancer/activator
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Provides innate protection, (4) Other, (5) Promotes antibody affinity maturation, (6) High stability. By routes: IM, IN, IP, IN, ID, IVag. Specify: Safe for systemic or mucosal administration
Point of Contact: Tulin Morcol, Captivate Pharma</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Tulin Morcol</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>CaPNP (CaPtivant)(TM)</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=11</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=11063495</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=12204953</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28716554</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28933657</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31591662</obo:IAO_0000119>
        <obo:VO_0005328>11</obo:VO_0005328>
        <rdfs:label>CaPNP (CaPtivant)(TM) vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005296 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005296">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule, other
Receptor: TLR4
Mechanism of Action: None
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: Other
Point of Contact: Robert Ernst, University of Maryland - Baltimore</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Robert Ernst</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>BECC470b</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=32</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28487429</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29861179</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33309485</obo:IAO_0000119>
        <obo:VO_0005328>32</obo:VO_0005328>
        <rdfs:label>BECC470b vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005297 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005297">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) Synthetic derivative of natural compound, (2) other
Receptor: TLR4
Mechanism of Action: None
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Robert Ernst, University of Maryland-Baltimore</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Robert Ernst</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>BECC438s</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=33</obo:IAO_0000119>
        <obo:VO_0005328>33</obo:VO_0005328>
        <rdfs:label>BECC438s vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005298 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005298">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule, other
Receptor: TLR4
Mechanism of Action: None
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Robert Ernst, University of Maryland Baltimore</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Robert Ernst</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>BECC438b</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=31</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28487429</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29861179</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33309485</obo:IAO_0000119>
        <obo:VO_0005328>31</obo:VO_0005328>
        <rdfs:label>BECC438b vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005299 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005299">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Combination adjuvant
Receptor: TLR4
Mechanism of Action: TLR4 and potentially inflammasome
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Darrick Carter, PAI Life Services</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Darrick Carter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>AlT4</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=19</obo:IAO_0000119>
        <obo:VO_0005328>19</obo:VO_0005328>
        <rdfs:label>AlT4 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005300 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005300">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005305"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Combination adjuvant
Receptor: TLR3
Mechanism of Action: TLR3 agonist plus potential inflammasome
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Darrick Carter, PAI Life Services</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Darrick Carter</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>AlT3</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=21</obo:IAO_0000119>
        <obo:VO_0005328>21</obo:VO_0005328>
        <rdfs:label>AlT3 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005301 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005301">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005306"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: (1) TLR7, (2) TLR8
Mechanism of Action: TLR7/8 dual agonist - lymph node delivery
Immune profile induced: Th1-biased
Other Features/Characteristics: Promotes antibody affinity maturation
Point of Contact: Sunil David, Virovax</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Sunil David</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Alhydroxiquim-II</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=12</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33521604</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33654090</obo:IAO_0000119>
        <obo:VO_0005328>12</obo:VO_0005328>
        <rdfs:label>Alhydroxiquim-II vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005302 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005302">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005314"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) Synthetic derivative of natural compound, (2) Emulsion, (3) Combination adjuvant, (4) Other
Receptor: TLR4
Mechanism of Action: Adjuplex enhances cross presentation to CD8 T cells and GLA stimulates TLR4 signaling
Immune profile induced: Mixed Th1/Th17
Other Features/Characteristics: None
Point of Contact: Marulasiddappa Suresh, UW Madison</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Marulasiddappa Suresh</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Adjuplex+GLA</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=15</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32984856</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33444400</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33767689</obo:IAO_0000119>
        <obo:VO_0005328>15</obo:VO_0005328>
        <rdfs:label>Adjuplex+GLA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005303 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005303">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Receptor: Dendritic cells (unknown receptor)
Mechanism of Action: Innate immune activation/enhancer
Immune profile induced: Mixed Th1/Th2
Other Features/Characteristics: None
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Amogh Madireddi</obo:IAO_0000117>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>2F52</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=8</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29751735</obo:IAO_0000119>
        <obo:VO_0005328>8</obo:VO_0005328>
        <rdfs:label>2F52 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005304 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005304"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005305 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005305"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005306 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005306"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005307 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005307"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005309 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005309"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005310 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005310"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005311 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005311"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005313 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005313"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005314 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005314"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005324 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005324">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0005357"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>An Advax-CpG vaccine adjuvant that includes an inulin-based polysaccharide (Advax) and a CpG oligodeoxynucleotide CpG55.2.</obo:IAO_0000115>
        <obo:IAO_0000116>Pubmed References:Chemical Nature: (1) combination adjuvant
Mechanism of Action: (1) complement, (2) dendritic cells, (3) other/unknown, (4) TLR9 Immune profile induced: mixed Th1
Other Features/Characteristics: (1) induces CD8 T cells, (2) provides innate protection, (3) anti-inflammatory, (4) promotes antibody affinity maturation, (5) effective in newborns, (6) high stability
By routes: SQ, IM
Point of Contact: Nikolai Petrovsky, Vaxine LTD</obo:IAO_0000116>
        <obo:IAO_0000117>Nikolai Petrovsky</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Advax-CpG55.2</obo:IAO_0000118>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/32636840/</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=38</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32849580</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33301675</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34069575</obo:IAO_0000119>
        <obo:VO_0005328>38</obo:VO_0005328>
        <rdfs:label>Advax-CpG55.2 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005325 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005325">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is synthesized by derivatizing a natural Momordica saponin in one step.  VSA-2 is chemically stable. VSA-2 is much less toxic than QS-21.  VSA-2 is more Th1-biased than QS-21. Momordica saponins are isolated from widely available and sustainable sources.</obo:IAO_0000115>
        <obo:IAO_0000116>Pubmed References:
Chemical Nature: (1) Synthetic derivative of natural compound
Mechanism of Action: unknown
Immune profile induced: mixed Th1/Th2
Other Features/Characteristics: (1) synthetic saponin with lower toxicity and higher stability than QS21
By routes: SQ
Point of Contact: Pengfei Wang, University of Alabama
https://www.ncbi.nlm.nih.gov/pubmed/?term=32101001</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Pengfei Wang</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>VSA-2</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=42</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32101001</obo:IAO_0000119>
        <obo:VO_0005328>42</obo:VO_0005328>
        <rdfs:label>VSA-2 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005326 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005326">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is prepared by derivatizing a natural Momordica saponin in one chemical step. VSA-1 is chemically more stable than QS-21. VSA-1 is much less toxic than QS-21. The Momordica saponins are from sustainable sources and widely available.</obo:IAO_0000115>
        <obo:IAO_0000116>Pubmed References:
Chemical Nature: (1) Synthetic derivative of natural compound
Mechanism of Action: unknown
Immune profile induced: mixed Th1/Th2
Other Features/Characteristics: (1) synthetic saponin with lower toxicity and higher stability than QS21
By routes: SQ
Point of Contact: Pengfei Wang, University of Alabama
https://www.ncbi.nlm.nih.gov/pubmed/?term=31657920</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Pengfei Wang</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>VSA-1</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=41</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31657920</obo:IAO_0000119>
        <obo:VO_0005328>41</obo:VO_0005328>
        <rdfs:label>VSA-1 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005327 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005327">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is a potent adjuvant for antibody and cellular responses to protein, polypeptide and small peptide antigens. rOv-ASP-1 stands for Recombinant Onchocerca volvulus activation-associated secreted protein-1.</obo:IAO_0000115>
        <obo:IAO_0000116>Pubmed References:
Chemical Nature: (1) Protein
Mechanism of Action: unknown
Immune profile induced: Th1
Other Features/Characteristics: (1) Induces CD8 T cells, (2) provides innate protection, (3) promotes antibody affinity maturation.
By routes: IM
Point of Contact: Sara Lustigman, New York Blood Center</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Sara Lustigman</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Recombinant O. volvulus activation-associated secreted protein-1</obo:IAO_0000118>
        <obo:IAO_0000118>rOv-ASP-1</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=43</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=1583768</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=18341617</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=18675867</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=22615877</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24681229</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25736195</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26795365</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29764680</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32471056</obo:IAO_0000119>
        <obo:VO_0005328>43</obo:VO_0005328>
        <rdfs:label>rOv-ASP-1 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005329 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005329">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005314"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes double mutant of heat-labile E. coli toxin (LT) at R192G/L211A or LT(R192G/L211A)</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: protein
Mechanism of Action: CGM1 ganglioside, cAMP, inflammasome
Immune profile induced: mixed Th1/Th17
Other Features/Characteristics: Induces mucosal immunity (IM, ID, SQ, SL, oral, , transcutaneous), Induces epitope spreading, Promotes antibody affinity maturation, Effective in newborns, promotes antibody epitope spreading
By routes: IM, ID, SL, oral, SQ, IN, IP, intragastric, transcutaneous, transdermal, buccal, intrarectal
Point of Contact: Elizabeth Norton, Tulane University

https://www.ncbi.nlm.nih.gov/pubmed/?term=21288994
https://www.ncbi.nlm.nih.gov/pubmed/?term=6803349
https://www.ncbi.nlm.nih.gov/pubmed/?term=26540197
https://www.ncbi.nlm.nih.gov/pubmed/?term=4927082
https://www.ncbi.nlm.nih.gov/pubmed/?term=26305793
https://www.ncbi.nlm.nih.gov/pubmed/?term=25111827
https://www.ncbi.nlm.nih.gov/pubmed/?term=24453241
https://www.ncbi.nlm.nih.gov/pubmed/?term=22202122
https://www.ncbi.nlm.nih.gov/pubmed/?term=25803825
https://www.ncbi.nlm.nih.gov/pubmed/?term=23541621
https://www.ncbi.nlm.nih.gov/pubmed/?term=26018536
https://www.ncbi.nlm.nih.gov/pubmed/?term=5461379
https://www.ncbi.nlm.nih.gov/pubmed/?term=3578125
https://www.ncbi.nlm.nih.gov/pubmed/?term=5216441
https://www.ncbi.nlm.nih.gov/pubmed/?term=19897067
https://www.ncbi.nlm.nih.gov/pubmed/?term=25944298
https://www.ncbi.nlm.nih.gov/pubmed/?term=6424635
https://www.ncbi.nlm.nih.gov/pubmed/?term=3916310
https://www.ncbi.nlm.nih.gov/pubmed/?term=4826740
https://www.ncbi.nlm.nih.gov/pubmed/?term=2884428
https://www.ncbi.nlm.nih.gov/pubmed/?term=30778066
https://www.ncbi.nlm.nih.gov/pubmed/?term=4893257
https://www.ncbi.nlm.nih.gov/pubmed/?term=28063704
https://www.ncbi.nlm.nih.gov/pubmed/?term=4375349
https://www.ncbi.nlm.nih.gov/pubmed/?term=28792004
https://www.ncbi.nlm.nih.gov/pubmed/?term=25765967
https://www.ncbi.nlm.nih.gov/pubmed/?term=25483682
https://www.ncbi.nlm.nih.gov/pubmed/?term=30638799
https://www.ncbi.nlm.nih.gov/pubmed/?term=21326197
https://www.ncbi.nlm.nih.gov/pubmed/?term=31757774
https://www.ncbi.nlm.nih.gov/pubmed/?term=31427449
https://www.ncbi.nlm.nih.gov/pubmed/?term=6957164
https://www.ncbi.nlm.nih.gov/pubmed/?term=33465933
https://www.ncbi.nlm.nih.gov/pubmed/?term=33465933
https://www.ncbi.nlm.nih.gov/pubmed/?term=33465933
https://www.ncbi.nlm.nih.gov/pubmed/?term=31641151
https://www.ncbi.nlm.nih.gov/pubmed/?term=27133878
https://www.ncbi.nlm.nih.gov/pubmed/?term=27676456
https://www.ncbi.nlm.nih.gov/pubmed/?term=27226279
https://www.ncbi.nlm.nih.gov/pubmed/?term=22406456
https://www.ncbi.nlm.nih.gov/pubmed/?term=30787109
https://www.ncbi.nlm.nih.gov/pubmed/?term=24403527
https://www.ncbi.nlm.nih.gov/pubmed/?term=24403527
https://www.ncbi.nlm.nih.gov/pubmed/?term=30563789
https://www.ncbi.nlm.nih.gov/pubmed/?term=31757774
https://www.ncbi.nlm.nih.gov/pubmed/?term=30473185
https://www.ncbi.nlm.nih.gov/pubmed/?term=30248001
https://www.ncbi.nlm.nih.gov/pubmed/?term=24049109
https://www.ncbi.nlm.nih.gov/pubmed/?term=30797634
https://www.ncbi.nlm.nih.gov/pubmed/?term=31482013
https://www.ncbi.nlm.nih.gov/pubmed/?term=29771685
https://www.ncbi.nlm.nih.gov/pubmed/?term=31757774
https://www.ncbi.nlm.nih.gov/pubmed/?term=25444830

Clinical trials:
https://clinicaltrials.gov/ct2/show/NCT03922061
https://clinicaltrials.gov/ct2/show/NCT04232943
https://clinicaltrials.gov/ct2/show/NCT02531685
https://clinicaltrials.gov/ct2/show/NCT02052934
https://clinicaltrials.gov/ct2/show/NCT02531802
https://clinicaltrials.gov/ct2/show/NCT01147445
https://clinicaltrials.gov/ct2/show/NCT03548064
https://clinicaltrials.gov/ct2/show/ NCT01739231
https://clinicaltrials.gov/ct2/show/NCT03404674
https://clinicaltrials.gov/ct2/show/NCT03729219
https://clinicaltrials.gov/ct2/show/NCT04826094</obo:IAO_0000116>
        <obo:IAO_0000117>Elizabeth Norton</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>dmLT</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=13</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=19897067</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21288994</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=22202122</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=23541621</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24453241</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25111827</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=25803825</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26018536</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26305793</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26540197</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=3578125</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=4927082</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=5216441</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=5461379</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=6803349</obo:IAO_0000119>
        <obo:VO_0005328>13</obo:VO_0005328>
        <rdfs:label>dmLT vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005330 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005330">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) other (Peptide)
Mechanism of Action: C5aR1 on mononuclear phagocytes
Immune profile induced: mixed Th1/Th2
Other Features/Characteristics: (1) Induces CD8 T cells, (2) provides innate protection, (3) promotes antibody affinity maturation.
By routes: SQ, IP, IV.
Point of Contact: Joseph Vetro, University of Nebraska Medical Center
https://pubmed.ncbi.nlm.nih.gov/9013982/, https://pubmed.ncbi.nlm.nih.gov/9013982/, https://pubmed.ncbi.nlm.nih.gov/10516626/, https://pubmed.ncbi.nlm.nih.gov/10799917/, https://pubmed.ncbi.nlm.nih.gov/10799917/, https://pubmed.ncbi.nlm.nih.gov/12538044/, https://pubmed.ncbi.nlm.nih.gov/19428909/, https://pubmed.ncbi.nlm.nih.gov/21723901/</obo:IAO_0000116>
        <obo:IAO_0000117>Joseph Vetro</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>CPDI-01</obo:IAO_0000118>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/10516626/</obo:IAO_0000119>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/10799917/</obo:IAO_0000119>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/12538044/</obo:IAO_0000119>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/19428909/</obo:IAO_0000119>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/21723901/</obo:IAO_0000119>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/9013982/</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=39</obo:IAO_0000119>
        <obo:VO_0005328>39</obo:VO_0005328>
        <rdfs:label>CPDI-01 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005337 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005337">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005306"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes UM-3005, a small molecule TLR7/8 agonist that can stimulate Th1-biased immune profile.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: (1) small molecule
Mechanism of Action: TLR7/8 agonist
Immune profile induced: Th1-biased
Route of immunization: IM
Point of Contact: Helene Bazin-Lee, InImmune</obo:IAO_0000116>
        <obo:IAO_0000117>Ani M. Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Helene Bazin-Lee</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>UM-3005</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=47</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/32210973</obo:IAO_0000119>
        <obo:VO_0005328>47</obo:VO_0005328>
        <rdfs:label>UM-3005 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005353 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005353">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005306"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes UM-3004, a small molecule TLR7/8 agonist that can stimulate Th1-biased immune profile.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: (1) small molecule
Mechanism of Action: TLR7/8 agonist
Immune profile induced: Th1-biased
Route of immunization: IM
Point of Contact: Helene Bazin-Lee, University of Montana</obo:IAO_0000116>
        <obo:IAO_0000117>Ani M. Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Helene Bazin-Lee</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>UM-3004</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=46</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/32210973</obo:IAO_0000119>
        <obo:VO_0005328>46</obo:VO_0005328>
        <rdfs:label>UM-3004 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005354 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005354">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005272"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005306"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes UM-3003, a small molecule TLR7/8 agonist that can stimulate Th1-biased immune profile.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: (1) small molecule
Mechanism of Action: TLR7/8 agonist
Immune profile induced: Th1-biased
Route of immunization: IM
Point of Contact: Helene Bazin-Lee, University of Montana</obo:IAO_0000116>
        <obo:IAO_0000117>Ani M. Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Helene Bazin-Lee</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>UM-3003</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=45</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/32210973</obo:IAO_0000119>
        <obo:VO_0005328>45</obo:VO_0005328>
        <rdfs:label>UM-3003 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005355 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005355">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005310"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005313"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant made from the A subunit of heat-labile (LT) enterotoxin of Enterotoxigenic Escherichia coli (ETEC). This LTA1 adjuvant is able to induce Th1, Th2, and Th17 immune responses.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: (1) Protein
Mechanism of Action: cAMP, inflammasome induction
Immune profile induced: mixed Th1/Th2/Th17
Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces epitope spreading, (3) Promotes antibody affinity maturation, (4) Promotes antibody epitope spreading, (5) High stability
Route of immunization: IM, IN, SL, ID, IP
Point of Contact: Elizabeth Norton, Tulane University</obo:IAO_0000116>
        <obo:IAO_0000117>Ani M. Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Elizabeth Norton</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>LTA1</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=44</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/22526674</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/26305793</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/31427449</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/31641151</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/31929548</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/33986280</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/34516780</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/6957164</obo:IAO_0000119>
        <obo:VO_0005328>44</obo:VO_0005328>
        <rdfs:label>LTA1 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005356 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005356">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <obo:IAO_0000115>A carbohydrate vaccine adjuvant that is a glucan carbohydrate microcapsules with a Œ≤(1-3)/Œ≤(1-6)-linked glucan structure to allow targeting of antigens to macrophages or neutrophils through interactions with the Œ≤-glucan receptor found uniquely on the surface of these cell types. Adjuvax-ligand complexes are formed by physically entrapping or crosslinking the ligand within the Œ≤-glucan.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000119>DOI: 10.1021</obo:IAO_0000119>
        <rdfs:label>Adjuvax vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005357 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005357">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes an inulin-based polysaccharide (Advax) and a CpG oligodeoxynucleotide (ODN).</obo:IAO_0000115>
        <obo:IAO_0000116>Pubmed References:Chemical Nature: (1) combination adjuvant
Mechanism of Action: (1) complement, (2) dendritic cells, (3) other/unknown, (4) TLR9 Immune profile induced: mixed Th1
Other Features/Characteristics: (1) induces CD8 T cells, (2) provides innate protection, (3) anti-inflammatory, (4) promotes antibody affinity maturation, (5) effective in newborns, (6) high stability
By routes: SQ, IM
Point of Contact: Nikolai Petrovsky, Vaxine LTD</obo:IAO_0000116>
        <obo:IAO_0000117>Nikolai Petrovsky</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Advax-2</obo:IAO_0000118>
        <obo:IAO_0000118>Advax-CpG</obo:IAO_0000118>
        <obo:IAO_0000118>Advax-SM</obo:IAO_0000118>
        <obo:IAO_0000119>https://pubmed.ncbi.nlm.nih.gov/32636840/</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32849580</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33301675</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34069575</obo:IAO_0000119>
        <rdfs:label>Advax-CpG vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005358 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005358">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <obo:IAO_0000115>A combination vaccine adjuvant includes 3-O-desacyl-4‚Äô-monophosphoryl lipid A (MPL) from Salmonella minnesota and a saponin molecule (QS-21) purified from plant extract Quillaja saponaria Molina, combined in a liposomal formulation consisting of dioleoyl phosphatidylcholine (DOPC) and cholesterol in phosphate-buffered saline solution.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000119>https://www.fda.gov/media/107538/download#:~:text=The%20AS01B%20adjuvant%20suspension%20is,DOPC)%20and%20cholesterol%20in%20phosphate%2D</obo:IAO_0000119>
        <rdfs:label>AS01B vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005359 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005359">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001264"/>
        <obo:IAO_0000115>An AS02 vaccine adjuvant contains 50 ug MPL and 50ug QS21, 250uL of SB62 (oil/water emulsion) in phosphate buffered saline (PBS) per volume of 0.5 mL.</obo:IAO_0000115>
        <obo:IAO_0000118>As02a</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT00308061</obo:IAO_0000119>
        <rdfs:label>AS02A vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005360 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005360">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <obo:IAO_0000115>A carbohydrate vaccine adjuvant that is aminoglycan consisting of Œ≤-(1-&gt;4)-linked¬†D-glucosamine residues.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000119>CHEBI:16261</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:24346613</obo:IAO_0000119>
        <rdfs:label>chitosan vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005361 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005361">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A Montanide vaccine adjuvant that is a water-dispersed liquid IMS 1313 nanoparticle combined with an immuno-stimulating compound.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>IMS 1313 N VGPR</obo:IAO_0000118>
        <obo:IAO_0000118>IMS-1313</obo:IAO_0000118>
        <obo:IAO_0000119>https://scialert.net/abstract/?doi=ijps.2018.167.174</obo:IAO_0000119>
        <rdfs:label>Montanide IMS 1313 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005362 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005362">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A water-dispersed liquid nanoparticle combined with an immuno-stimulating compound.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>ISA-206</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:8961504</obo:IAO_0000119>
        <rdfs:label>Montanide ISA 206 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005363 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005363">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001271"/>
        <obo:IAO_0000115>A Montanide vaccine adjuvant that Mannide oleate derivative in a mineral oil solution ( Seppic SA, France).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>ISA-50</obo:IAO_0000118>
        <obo:IAO_0000119>http://vetarhiv.vef.unizg.hr/papers/74-2/raman.pdf</obo:IAO_0000119>
        <rdfs:label>Montanide ISA 50 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005364 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005364">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <obo:IAO_0000115>A carbohydrate vaccine adjuvant that is tomatidine in which the hydroxy group at position 3 is linked to lycotetraose, a tetrasaccharide composed of two units of D-glucose, one unit of D-xylose, and one unit of D-galactose.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000119>CHEBI:9630</obo:IAO_0000119>
        <rdfs:label>Tomatine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005365 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005365">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001359"/>
        <obo:IAO_0000115>A carbohydrate vaccine adjuvant that polysaccharide prepared from the cell wall of Saccaromyces cerevisiae (bakers&apos; yeast).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:11380697</obo:IAO_0000119>
        <rdfs:label>Zymosan vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005366 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005366">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that is oil-based adjuvant (Adjuvant XtendIII®; Grand Laboratories, Larchwood, IA).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <rdfs:label>XtendIII vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005367 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005367">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000118"/>
        <obo:IAO_0000115>A microbial derivative vaccine adjuvant that is monophosphoryl lipid A (detoxified endotoxin) from S. minnesota (MPL) and synthetic trehalose dicorynomycolate (TDM) in 2% oil (squalene)-Tween 80-water.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>Monophosphoryl-lipid A + Trehalose dicorynomycolate</obo:IAO_0000118>
        <obo:IAO_0000119>https://www.sigmaaldrich.com/US/en/product/sigma/m6536</obo:IAO_0000119>
        <rdfs:label>MPL + TDM vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005368 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005368">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000187"/>
        <obo:IAO_0000115>A muramyl dipeptide vaccine adjuvant that muramyl dipeptide derivative (threonyl-MDP) in an oil-in-water (o/w) emulsion vehicle.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>SAF</obo:IAO_0000118>
        <obo:IAO_0000119>https://link.springer.com/protocol/10.1385/1-59259-083-7:229</obo:IAO_0000119>
        <rdfs:label>Syntex Adjuvant Formulation</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005369 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005369">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005313"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that diester obtained by the formal condensation of the carboxy groups of phthalic acid with two molecules of butan-1-ol.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>DBP</obo:IAO_0000118>
        <obo:IAO_0000119>CHEBI:34687</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:26319029</obo:IAO_0000119>
        <rdfs:label>dibutyl phthalate vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005370 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005370">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005313"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that includes naturally occurring trivalent alcohol.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>glycerine, 1, 2, 3-propanetriol</obo:IAO_0000118>
        <obo:IAO_0000119>https://academic.oup.com/cid/article/45/10/1277/277413</obo:IAO_0000119>
        <rdfs:label>glycerol vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005371 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005371">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005313"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant includes three palmitic acid groups that are bound in an ester and amide linkage to a cysteine residue.</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000118>Tripalmitoyl-S-glyceryl-cysteine</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:24130558</obo:IAO_0000119>
        <rdfs:label>Pam3Cys vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005372 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005372">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005313"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is equimolar mixture of the cationic lipid GAP-DMORIE [(±)-N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(cis-9-tetradecenyloxy)-1-propanaminium bromide)] and a neutral colipid DPyPE (1,2-diphytanoyl-sn-glydero-3-phosphoethanolamine).</obo:IAO_0000115>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Randi Vita</obo:IAO_0000117>
        <obo:IAO_0000119>PMID:21118032</obo:IAO_0000119>
        <rdfs:label>Vaxfectin vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005375 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005375">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005378"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005376"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005377"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/PR_000001155"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005377"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/PR_000011271"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuant that is derived from Salmonella enterica serovar typhimurium and is able to induce Th1/Th2/Th17 immune responses through the mechanism of action of TLR4, inflammasome, and DC activation.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: TLR4; inflammasome; DC activation
Immune profile induced: Th1/Th2/Th17
Receptor: TLR4, NLRP3
Storage information: -20 or -80C
Point of Contact: Lisa Morici, Tulane University</obo:IAO_0000116>
        <obo:IAO_0000117>Lisa Morici</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>T-vant</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=61</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33498352</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34069796</obo:IAO_0000119>
        <obo:VO_0005328>61</obo:VO_0005328>
        <rdfs:label>T-vant vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005376 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005376"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005378 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005378"/>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005379 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005379">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: Nucleic Acid
Mechanism of Action: TLR/RLR-agonist
Immune profile induced: Th1/Th2

Route of immunization: IM and IN
Point of Contact: Xiaoliang Ren, Yisheng Bio

Ongoing clinical trial:
https://clinicaltrials.gov/ct2/show/NCT02657161
https://clinicaltrials.gov/ct2/show/NCT02956421</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000117>Xiaoliang Ren</obo:IAO_0000117>
        <obo:IAO_0000118>PIKA</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=55</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=17484805</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=20538850</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21468931</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26765968</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28118938</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29174316</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34766005</obo:IAO_0000119>
        <obo:VO_0005328>55</obo:VO_0005328>
        <rdfs:label>PIKA vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005380 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005380">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005310"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: peptide
Mechanism of Action: activation of mast cells, epithelial cells, macrophages and dendritic cells
Immune profile induced: Th2-biased

Route of immunization: IM and IN
Point of Contact: Herman Staats, Duke University</obo:IAO_0000116>
        <obo:IAO_0000117>Herman Staats</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Mastoparan 7</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=53</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31068425</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32047657</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34566991</obo:IAO_0000119>
        <obo:VO_0005328>53</obo:VO_0005328>
        <rdfs:label>Mastoparan 7 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005381 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005381">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005310"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: mast cell activation
Immune profile induced: Th2-biased

Route of immunization: IN
Point of Contact: Herman Staats, Duke University</obo:IAO_0000116>
        <obo:IAO_0000117>Herman Staats</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Mast cell activator small molecules</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=54</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34566991</obo:IAO_0000119>
        <obo:VO_0005328>54</obo:VO_0005328>
        <rdfs:label>Mast cell activator small molecules vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005382 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005382">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Ofer Levy, Precision Vaccines Program at Boston Children&apos;s Hospital</obo:IAO_0000116>
        <obo:IAO_0000117>Ofer Levy</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Precision Vaccines Program (PVP)-037</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=56</obo:IAO_0000119>
        <obo:VO_0005328>56</obo:VO_0005328>
        <rdfs:label>Precision Vaccines Program (PVP)-037 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005383 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005383">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: TLR4 agonist
Immune profile induced: Th1/Th2

Route of immunization: IM and IN
Point of Contact: Robert Ernst, University of Maryland - Baltimore</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Robert Ernst</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>BECC470s</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=60</obo:IAO_0000119>
        <obo:VO_0005328>60</obo:VO_0005328>
        <rdfs:label>BECC470s vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005384 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005384">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: innate immune activation
Immune profile induced: Th1-biased
Route of immunization: IM
Point of Contact: Helene Bazin-Lee, University of Montana</obo:IAO_0000116>
        <obo:IAO_0000117>Helene Bazin-Lee</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>TRAC478</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=48</obo:IAO_0000119>
        <obo:VO_0005328>48</obo:VO_0005328>
        <rdfs:label>TRAC478 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005385 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005385">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005314"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: innate immune activation
Immune profile induced: Th1/Th17

Route of immunization: IM and IN
Point of Contact: Christopher Fox, AAHI</obo:IAO_0000116>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>GLA-3M-052-LS</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=58</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34248966</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34795290</obo:IAO_0000119>
        <obo:VO_0005328>58</obo:VO_0005328>
        <rdfs:label>GLA-3M-052-LS vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005386 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005386">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: innate immune activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI</obo:IAO_0000116>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>3M-052-SE</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=57</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28429728</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30089691</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32213623</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34131024</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34972105</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35572573</obo:IAO_0000119>
        <obo:VO_0005328>57</obo:VO_0005328>
        <rdfs:label>3M-052-SE vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005387 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005387">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: innate immune activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI

Clinical trials:
https://clinicaltrials.gov/ct2/show/NCT04177355
https://clinicaltrials.gov/ct2/show/NCT04915768
https://clinicaltrials.gov/ct2/show/NCT05197712</obo:IAO_0000116>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>3M-052-Alum</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=59</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32561559</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33971664</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34117252</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34266981</obo:IAO_0000119>
        <obo:VO_0005328>59</obo:VO_0005328>
        <rdfs:label>3M-052-Alum vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005388 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005388">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005314"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) emulsion
Mechanism of Action: unknown
Immune profile induced: Th1/Th17

Route of immunization: IM
Point of Contact: Patrice Dubois, Vaccine Formulation Institute

Clinical trial:
https://clinicaltrials.gov/ct2/show/NCT04702178</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Patrice Dubois</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SWE</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=50</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30849373</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32411401</obo:IAO_0000119>
        <obo:VO_0005328>50</obo:VO_0005328>
        <rdfs:label>SWE vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005389 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005389">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) Emulsion (with Saponin)
Mechanism of Action: unknown
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Patrice Dubois, Vaccine Formulation Institute</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Patrice Dubois</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SQ</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=52</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33688647</obo:IAO_0000119>
        <obo:VO_0005328>52</obo:VO_0005328>
        <rdfs:label>SQ vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005390 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005390">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: (1) other (liposome with Saponin)
Mechanism of Action: unknown
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Patrice Dubois, Vaccine Formulation Institute</obo:IAO_0000116>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Patrice Dubois</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>LQ</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=51</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32156809</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33688647</obo:IAO_0000119>
        <obo:VO_0005328>51</obo:VO_0005328>
        <rdfs:label>LQ vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005419 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005419">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: Activation of APCs, activation of T cells and stimulating B cell proliferation (IgG)
Immune profile induced: Th1-biased

Route of immunization: IM and SQ
Point of Contact: Matthew Heath, Allergy Therapeutics (UK) Ltd</obo:IAO_0000116>
        <obo:IAO_0000117>Ani Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Matthew Heath</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>MCT</obo:IAO_0000118>
        <obo:IAO_0000118>MCT vaccine adjuvant</obo:IAO_0000118>
        <obo:IAO_0000118>MicroCrystalline Tyrosine</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=25</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28347293</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28468322</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=28953265</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29592962</obo:IAO_0000119>
        <obo:VO_0005328>25</obo:VO_0005328>
        <rdfs:label>MicroCrystalline Tyrosine vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005420 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005420">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: TLR4; Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=27142329
https://www.ncbi.nlm.nih.gov/pubmed/?term=21060869
https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089
https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089
https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089
https://www.ncbi.nlm.nih.gov/pubmed/?term=21816196
https://www.ncbi.nlm.nih.gov/pubmed/?term=21690242
https://www.ncbi.nlm.nih.gov/pubmed/?term=21060869
https://www.ncbi.nlm.nih.gov/pubmed/?term=22291184
https://www.ncbi.nlm.nih.gov/pubmed/?term=22291184
https://www.ncbi.nlm.nih.gov/pubmed/?term=23045649
https://www.ncbi.nlm.nih.gov/pubmed/?term=23045649
https://www.ncbi.nlm.nih.gov/pubmed/?term=22509423
https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687
https://www.ncbi.nlm.nih.gov/pubmed/?term=23904160
https://www.ncbi.nlm.nih.gov/pubmed/?term=23954378
https://www.ncbi.nlm.nih.gov/pubmed/?term=22425788
https://www.ncbi.nlm.nih.gov/pubmed/?term=22891286
https://www.ncbi.nlm.nih.gov/pubmed/?term=22891286
https://www.ncbi.nlm.nih.gov/pubmed/?term=23624057
https://www.ncbi.nlm.nih.gov/pubmed/?term=23624057
https://www.ncbi.nlm.nih.gov/pubmed/?term=23228811
https://www.ncbi.nlm.nih.gov/pubmed/?term=25024362
https://www.ncbi.nlm.nih.gov/pubmed/?term=25030053
https://www.ncbi.nlm.nih.gov/pubmed/?term=24404140
https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505
https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505
https://www.ncbi.nlm.nih.gov/pubmed/?term=24397898
https://www.ncbi.nlm.nih.gov/pubmed/?term=24397898
https://www.ncbi.nlm.nih.gov/pubmed/?term=24728521
https://www.ncbi.nlm.nih.gov/pubmed/?term=24728521
https://www.ncbi.nlm.nih.gov/pubmed/?term=25367751
https://www.ncbi.nlm.nih.gov/pubmed/?term=26541135
https://www.ncbi.nlm.nih.gov/pubmed/?term=25637347
https://www.ncbi.nlm.nih.gov/pubmed/?term=27005808
https://www.ncbi.nlm.nih.gov/pubmed/?term=26656121
https://www.ncbi.nlm.nih.gov/pubmed/?term=26874325
https://www.ncbi.nlm.nih.gov/pubmed/?term=26791076
https://www.ncbi.nlm.nih.gov/pubmed/?term=27466350
https://www.ncbi.nlm.nih.gov/pubmed/?term=27699241
https://www.ncbi.nlm.nih.gov/pubmed/?term=29176865
https://www.ncbi.nlm.nih.gov/pubmed/?term=27958370
https://www.ncbi.nlm.nih.gov/pubmed/?term=29263879
https://www.ncbi.nlm.nih.gov/pubmed/?term=29795025
https://www.ncbi.nlm.nih.gov/pubmed/?term=29983563
https://www.ncbi.nlm.nih.gov/pubmed/?term=29619252
https://www.ncbi.nlm.nih.gov/pubmed/?term=29619252
https://www.ncbi.nlm.nih.gov/pubmed/?term=27895131
https://www.ncbi.nlm.nih.gov/pubmed/?term=32636844
https://www.ncbi.nlm.nih.gov/pubmed/?term=29541075
https://www.ncbi.nlm.nih.gov/pubmed/?term=33705411
https://www.ncbi.nlm.nih.gov/pubmed/?term=35126135
https://www.ncbi.nlm.nih.gov/pubmed/?term=19679214
https://www.ncbi.nlm.nih.gov/pubmed/?term=26731269
https://www.ncbi.nlm.nih.gov/pubmed/?term=26453448
https://www.ncbi.nlm.nih.gov/pubmed/?term=26453448
https://www.ncbi.nlm.nih.gov/pubmed/?term=27456709
https://www.ncbi.nlm.nih.gov/pubmed/?term=32023469
https://www.ncbi.nlm.nih.gov/pubmed/?term=32402293
https://www.ncbi.nlm.nih.gov/pubmed/?term=32348377
https://www.ncbi.nlm.nih.gov/pubmed/?term=32697993
https://www.ncbi.nlm.nih.gov/pubmed/?term=29515589
https://www.ncbi.nlm.nih.gov/pubmed/?term=33046728
https://www.ncbi.nlm.nih.gov/pubmed/?term=31690678
https://www.ncbi.nlm.nih.gov/pubmed/?term=31174937
https://www.ncbi.nlm.nih.gov/pubmed/?term=30567978
https://www.ncbi.nlm.nih.gov/pubmed/?term=31362695
https://www.ncbi.nlm.nih.gov/pubmed/?term=29769270
https://www.ncbi.nlm.nih.gov/pubmed/?term=31521953
https://www.ncbi.nlm.nih.gov/pubmed/?term=28298421

Ongoing clinical trial:
https://clinicaltrials.gov/ct2/show/NCT01484548
https://clinicaltrials.gov/ct2/show/NCT01751048
https://clinicaltrials.gov/ct2/show/NCT02071758
https://clinicaltrials.gov/ct2/show/NCT02465216
https://clinicaltrials.gov/ct2/show/NCT01927159
https://clinicaltrials.gov/ct2/show/NCT01599897
https://clinicaltrials.gov/ct2/show/NCT01154049
https://clinicaltrials.gov/ct2/show/NCT03302897
https://clinicaltrials.gov/ct2/show/NCT02465216
https://clinicaltrials.gov/ct2/show/NCT02508376
https://clinicaltrials.gov/ct2/show/NCT03806686
https://clinicaltrials.gov/ct2/show/NCT01949909
https://clinicaltrials.gov/ct2/show/NCT01540474
https://clinicaltrials.gov/ct2/show/NCT02014727
https://clinicaltrials.gov/ct2/show/NCT02647489
https://clinicaltrials.gov/ct2/show/NCT02658253
https://clinicaltrials.gov/ct2/show/NCT01991561
https://clinicaltrials.gov/ct2/show/NCT01596725
https://clinicaltrials.gov/ct2/show/NCT01147068
https://clinicaltrials.gov/ct2/show/NCT03820414
https://clinicaltrials.gov/ct2/show/NCT03220724
https://clinicaltrials.gov/ct2/show/NCT03409276
https://clinicaltrials.gov/ct2/show/NCT01864876
https://clinicaltrials.gov/ct2/show/NCT02115815
https://clinicaltrials.gov/ct2/show/NCT01397604</obo:IAO_0000116>
        <obo:IAO_0000117>Ani Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>GLA-SE</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT01484548</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT01751048</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT02071758</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=62</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21060869</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=27142329</obo:IAO_0000119>
        <obo:VO_0005328>62</obo:VO_0005328>
        <rdfs:label>GLA-SE vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005421 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005421">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: TLR4; Innate Immune Activation
Immune profile induced: Mixed Th1/Th2

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI

Ongoing clinical trial:
https://clinicaltrials.gov/ct2/show/NCT02508376
https://clinicaltrials.gov/ct2/show/NCT02647489
https://clinicaltrials.gov/ct2/show/NCT04177355
https://clinicaltrials.gov/ct2/show/NCT03589794</obo:IAO_0000116>
        <obo:IAO_0000117>Ani Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>GLA-SLQ</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=63</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24465426</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26541135</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26862758</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31174937</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31690678</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32636844</obo:IAO_0000119>
        <obo:VO_0005328>63</obo:VO_0005328>
        <rdfs:label>GLA-SLQ vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005422 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005422">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: TLR4; Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI</obo:IAO_0000116>
        <obo:IAO_0000117>Ani Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SLA-LSQ</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=64</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30302281</obo:IAO_0000119>
        <obo:VO_0005328>64</obo:VO_0005328>
        <rdfs:label>SLA-LSQ vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005423 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005423">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: TLR4; Innate Immune Activation
Immune profile induced: n/a

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI

Ongoing clinical trial:
https://clinicaltrials.gov/ct2/show/NCT03820414
https://clinicaltrials.gov/ct2/show/NCT02071758</obo:IAO_0000116>
        <obo:IAO_0000117>Ani Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SLA-SE</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=65</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30386348</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31149350</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31891152</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32540272</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35459225</obo:IAO_0000119>
        <obo:VO_0005328>65</obo:VO_0005328>
        <rdfs:label>SLA-SE vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005424 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005424">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005304"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Chemical Nature: other
Mechanism of Action: TLR4; Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Christopher Fox, AAHI

Ongoing clinical trial:
https://clinicaltrials.gov/ct2/show/NCT02508376
https://clinicaltrials.gov/ct2/show/NCT02647489
https://clinicaltrials.gov/ct2/show/NCT04177355
https://clinicaltrials.gov/ct2/show/NCT03589794</obo:IAO_0000116>
        <obo:IAO_0000117>Ani Bernardi</obo:IAO_0000117>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Christopher Fox</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>GLA-AF</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=66</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24465426</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26541135</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26862758</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31174937</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31690678</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32636844</obo:IAO_0000119>
        <obo:VO_0005328>66</obo:VO_0005328>
        <rdfs:label>GLA-AF vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005471 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005471">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant 30:70 (w/w) Water-in-Oil  (W/O) emulsion that stimulates a mixed Th1/Th2 response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: emulsion
Mechanism of Action: adjuvanted antigen depot at injection site
Immune profile induced: Mixed Th1/Th2

Route of immunization: IM and SQ
Point of Contact: Peter Blackburn, MerciaPharma

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=23595760
https://www.ncbi.nlm.nih.gov/pubmed/?term=24783964
https://www.ncbi.nlm.nih.gov/pubmed/?term=34429319
https://www.ncbi.nlm.nih.gov/pubmed/?term=34926305

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT02500680
https://clinicaltrials.gov/ct2/show/NCT02500680
https://clinicaltrials.gov/ct2/show/NCT03624062
https://clinicaltrials.gov/ct2/show/NCT02118077</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Peter Blackburn</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>MAS-1</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT02118077</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT02500680</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT03624062</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=68</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=23595760</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24783964</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34429319</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34926305</obo:IAO_0000119>
        <obo:VO_0005328>68</obo:VO_0005328>
        <rdfs:label>MAS-1 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005472 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005472">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that induces CD8 T cells and provides innate protection.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: small molecule
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: SQ
Point of Contact: Taegyan Kang, Progeneer

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=36635335

Ongoing clinical trials: n/a</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Taegyan Kang</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>ProLNG-S</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=34</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=36635335</obo:IAO_0000119>
        <obo:VO_0005328>34</obo:VO_0005328>
        <rdfs:label>ProLNG-S vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005473 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005473">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is a lipid-based vaccine adjuvent based on cationic surfactant dimethyl-dioctadecyl ammonium (DDA) combined with C-type lectin agonist monomycoloyl glycerol (MMG) and TLR3 agonist poly I:C. CAF09b is able to induce CD8+ T-cell response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Liposome
Mechanism of Action: n/a
Immune profile induced: n/a

Route of immunization: IN, IP, IM,
Point of Contact: Gabriel Kristian Pedersen, Staten Serum Institute (SSI)

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=35163772
https://www.ncbi.nlm.nih.gov/pubmed/?term=33352684
https://www.ncbi.nlm.nih.gov/pubmed/?term=35036074

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT03715985</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Gabriel Kristian Pedersen</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>CAF09b</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT03715985</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=76</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33352684</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35036074</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35163772</obo:IAO_0000119>
        <obo:VO_0005328>76</obo:VO_0005328>
        <rdfs:label>CAF09b vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005474 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005474">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is a lipid-based nanosuspension of a synthetic TLR7/8 ligand that facilitates adsorption to aluminum oxyhydroxide via the structural properties of the helper lipid employed.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Valerie Soza, AAHI

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326
https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326
https://www.ncbi.nlm.nih.gov/pubmed/?term=36274085

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT04177355
https://clinicaltrials.gov/ct2/show/NCT05781542
https://clinicaltrials.gov/ct2/show/NCT05471076
https://clinicaltrials.gov/ct2/show/NCT04915768
https://clinicaltrials.gov/ct2/show/NCT05781542</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>3M-052-AF</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT04177355</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT04915768</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT05471076</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT05781542</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=69</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=36274085</obo:IAO_0000119>
        <obo:VO_0005328>69</obo:VO_0005328>
        <rdfs:label>3M-052-AF vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005475 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005475">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that reformulates Alhydrogel as a stable nanoparticle with the anionic polymer polyacrylic acid (PAA), leading to the induction of structure-dependent TH1 response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Valerie Soza, AAHI

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=30622742
https://www.ncbi.nlm.nih.gov/pubmed/?term=31930264</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>NanoAlum</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=71</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30622742</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31930264</obo:IAO_0000119>
        <obo:VO_0005328>71</obo:VO_0005328>
        <rdfs:label>NanoAlum vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005476 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005476">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant is a small molecule adjuvant that induces Th1-based immune response and is designed for use with self-amplifying RNA antigens.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Valerie Soza, AAHI

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=35911728
https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202
https://www.ncbi.nlm.nih.gov/pubmed/?term=34058388
https://www.ncbi.nlm.nih.gov/pubmed/?term=35308783
https://www.ncbi.nlm.nih.gov/pubmed/?term=36589712
https://www.ncbi.nlm.nih.gov/pubmed/?term=36323666

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT05370040</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>NLC vaccine adjuvant</obo:IAO_0000118>
        <obo:IAO_0000118>Nanostructured Lipid Carrier</obo:IAO_0000118>
        <obo:IAO_0000118>Nanostructured Lipid Carrier (NLC)</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT05370040</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=70</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34058388</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35308783</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35911728</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=36323666</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=36589712</obo:IAO_0000119>
        <obo:VO_0005328>70</obo:VO_0005328>
        <rdfs:label>Nanostructured Lipid Carrier (NLC) vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005482 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005482">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant is an oil-in-water emulsion that induces Th1-based immune response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Mechanism of Action: Innate Immune Activation
Immune profile induced: n/a

Route of immunization: IM
Point of Contact: Valerie Soza, AAHI

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=32983577
https://www.ncbi.nlm.nih.gov/pubmed/?term=35459225</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SLA-AF</obo:IAO_0000118>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=72</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32983577</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=35459225</obo:IAO_0000119>
        <obo:VO_0005328>72</obo:VO_0005328>
        <rdfs:label>SLA-AF vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0005483 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0005483">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005314"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant is a gadoteridol-loaded cationic adjuvant formulation 01 that induced a Th1/Th17 type of immune response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Liposome system
Mechanism of Action: n/a
Immune profile induced: Th1/Th17

Route of immunization: IP, IM, IN, SQ, ID, SC, SL, intratracheal, endotracheal, Fish vaccination
Point of Contact: Gabriel Kristian Pedersen, Staten Serum Institute (SSI)

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=31539263
https://www.ncbi.nlm.nih.gov/pubmed/?term=30555488
https://www.ncbi.nlm.nih.gov/pubmed/?term=29699790
https://www.ncbi.nlm.nih.gov/pubmed/?term=34044110
https://www.ncbi.nlm.nih.gov/pubmed/?term=26394776
https://www.ncbi.nlm.nih.gov/pubmed/?term=18776936
https://www.ncbi.nlm.nih.gov/pubmed/?term=30291987
https://www.ncbi.nlm.nih.gov/pubmed/?term=21124731
https://www.ncbi.nlm.nih.gov/pubmed/?term=29358939
https://www.ncbi.nlm.nih.gov/pubmed/?term=33072125
https://www.ncbi.nlm.nih.gov/pubmed/?term=35585969
https://www.ncbi.nlm.nih.gov/pubmed/?term=26494626
https://www.ncbi.nlm.nih.gov/pubmed/?term=26379666
https://www.ncbi.nlm.nih.gov/pubmed/?term=35124896
https://www.ncbi.nlm.nih.gov/pubmed/?term=34358167
https://www.ncbi.nlm.nih.gov/pubmed/?term=29541075
https://www.ncbi.nlm.nih.gov/pubmed/?term=31130946
https://www.ncbi.nlm.nih.gov/pubmed/?term=31906072
https://www.ncbi.nlm.nih.gov/pubmed/?term=32106599
https://www.ncbi.nlm.nih.gov/pubmed/?term=19492047
https://www.ncbi.nlm.nih.gov/pubmed/?term=33422991
https://www.ncbi.nlm.nih.gov/pubmed/?term=28414746
https://www.ncbi.nlm.nih.gov/pubmed/?term=33066267
https://www.ncbi.nlm.nih.gov/pubmed/?term=27958370
https://www.ncbi.nlm.nih.gov/pubmed/?term=23308247
https://www.ncbi.nlm.nih.gov/pubmed/?term=30984200
https://www.ncbi.nlm.nih.gov/pubmed/?term=20505822
https://www.ncbi.nlm.nih.gov/pubmed/?term=27525651
https://www.ncbi.nlm.nih.gov/pubmed/?term=23873630

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT00922363
https://clinicaltrials.gov/ct2/show/NCT01009762
https://clinicaltrials.gov/ct2/show/NCT02787109
https://clinicaltrials.gov/ct2/show/NCT01141205
https://clinicaltrials.gov/ct2/show/NCT03926728</obo:IAO_0000116>
        <obo:IAO_0000117>Ari Joffe</obo:IAO_0000117>
        <obo:IAO_0000117>Gabriel Kristian Pedersen</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>CAF01</obo:IAO_0000118>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT00922363</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT01009762</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT01141205</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT02787109</obo:IAO_0000119>
        <obo:IAO_0000119>https://clinicaltrials.gov/ct2/show/NCT03926728</obo:IAO_0000119>
        <obo:IAO_0000119>https://vac.niaid.nih.gov/view?id=75</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=18776936</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=21124731</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=26394776</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29358939</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=29699790</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30291987</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=30555488</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=31539263</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34044110</obo:IAO_0000119>
        <obo:VO_0005328>75</obo:VO_0005328>
        <rdfs:label>CAF01 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006092 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006092">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A combination vaccine adjuvant that is liposome-based adjuvant of a synthetic TLR agonist and saponin induced a Th1-biased immune response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Combination adjuvant
Mechanism of Action: n/a
Immune profile induced: Th1-biased
Route of immunization: IM
Point of Contact: Maria Lawrenz, Vaccine Formulation Institute</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Maria Lawrenz</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>LMQ</obo:IAO_0000118>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=36119058</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=36634821</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=37029167</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/614</obo:IAO_0000233>
        <obo:VO_0005328>78</obo:VO_0005328>
        <rdfs:label>LMQ vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006093 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006093">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005376"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant that is a peptide which is able to induce Th1/Th2/Th17 immune responses through the mechanism of selectively activates C5aR1 on mononuclear phagocytes vs neutrophils.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Other - Peptide
Mechanism of Action: (Primary) Selectively activates C5aR1 on mononuclear phagocytes vs neutrophils
Immune profile induced: Th1/Th2/Th17
Route of immunization: IP, IV
Point of Contact: Joseph Vetro, University of Nebraska Medical Center</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Joseph Vetro</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>CPDI-02</obo:IAO_0000118>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=11710544</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=19836478</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=20965299</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/615</obo:IAO_0000233>
        <obo:VO_0005328>40</obo:VO_0005328>
        <rdfs:label>CPDI-02 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006094 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006094">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant with a Toll-like receptor 9 (TLR9)-active oligonucleotide that is able to induce Th1/Th2 immune responses.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Nucleic acid
Mechanism of Action: TLR9 agonist
Immune profile induced: Mixed Th1/Th2
Route of immunization: IM, SQ
Point of Contact: Nikolai Petrovsky, Vaxine LTD
</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nikolai Petrovsky</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>CpG55.2</obo:IAO_0000118>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=24554695</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=27387453</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32156809</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=32418798</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=33479242</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34399628</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34420786</obo:IAO_0000119>
        <obo:IAO_0000119>https://www.ncbi.nlm.nih.gov/pubmed/?term=34456075</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/616</obo:IAO_0000233>
        <obo:VO_0005328>10</obo:VO_0005328>
        <rdfs:label>CpG55.2 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006095 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006095">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A combination vaccine adjuvant that includes AS01-mimic, Immune Stimulating Complex (ISCOM) with a TLR4 agonist.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Combination adjuvant
Mechanism of Action: Cytokine induction in draining lymph nodes with increased lymph flow and lymph antigen accumulation
Immune profile induced: Mixed Th1/Th2
Route of immunization: s.c. / i.m. / i.n.
Point of Contact: Katarzyna Kaczmarek Michaels, Massachusetts Institute of Technology
Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=34860581
https://www.ncbi.nlm.nih.gov/pubmed/?term=36131022
https://www.ncbi.nlm.nih.gov/pubmed/?term=34878851</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Katarzyna Kaczmarek Michaels</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SMNP</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/632</obo:IAO_0000233>
        <obo:VO_0005328>77</obo:VO_0005328>
        <rdfs:label>SMNP vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006096 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006096">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A combination vaccine adjuvant that is an AS01-mimic, liposomal adjuvant of a TLR4 agonist and saponin.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature:
- Natural compound
- Synthetic derivative of natural compound
- Combination adjuvant
Mechanism of Action: MPLA: TLR4 agonist QS21: Sugar-lawn likely recog. by lectins to facilitate uptake by M_, DCs, etc
Immune profile induced: Mixed Th1/Th2
Route of immunization: ID, IM
Point of Contact: Mangala Rao, Walter Reed Army Institute of Research
Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=34202178
https://www.ncbi.nlm.nih.gov/pubmed/?term=31827000
https://www.ncbi.nlm.nih.gov/pubmed/?term=34470866
https://www.ncbi.nlm.nih.gov/pubmed/?term=35632473
https://www.ncbi.nlm.nih.gov/pubmed/?term=36417525
https://www.ncbi.nlm.nih.gov/pubmed/?term=34914540
https://www.ncbi.nlm.nih.gov/pubmed/?term=32881968
https://www.ncbi.nlm.nih.gov/pubmed/?term=26372857
https://www.ncbi.nlm.nih.gov/pubmed/?term=36055874
https://www.ncbi.nlm.nih.gov/pubmed/?term=34202178
https://www.ncbi.nlm.nih.gov/pubmed/?term=36679887
https://www.ncbi.nlm.nih.gov/pubmed/?term=36934088
https://www.ncbi.nlm.nih.gov/pubmed/?term=34903722
https://www.ncbi.nlm.nih.gov/pubmed/?term=31775762
https://www.ncbi.nlm.nih.gov/pubmed/?term=28596090
https://www.ncbi.nlm.nih.gov/pubmed/?term=31151801
https://www.ncbi.nlm.nih.gov/pubmed/?term=34711815
https://www.ncbi.nlm.nih.gov/pubmed/?term=34159328
Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT04268420
https://clinicaltrials.gov/ct2/show/NCT04296279
https://clinicaltrials.gov/ct2/show/NCT04784767
https://clinicaltrials.gov/ct2/show/NCT05500417
https://clinicaltrials.gov/ct2/show/NCT04826094
https://clinicaltrials.gov/ct2/show/NCT04658667
https://clinicaltrials.gov/ct2/show/NCT05423418</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Mangala Rao</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>ALFQ</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/633</obo:IAO_0000233>
        <obo:VO_0005328>79</obo:VO_0005328>
        <rdfs:label>ALFQ vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006097 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006097">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant which is a small molecule TLR agonist that drives a mixed Th1/Th2 response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature:
Small molecule
Mechanism of Action: Innate immune activation
Immune profile induced: Mixed Th1/Th2
Route of immunization: IM
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>2G023A</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/648</obo:IAO_0000233>
        <obo:VO_0005328>81</obo:VO_0005328>
        <rdfs:label>2G023A vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006098 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006098">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant, a small molecule TLR agonist that drives a mixed Th1/Th2 response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature:
Small molecule
Mechanism of Action: Innate immune activation
Immune profile induced: Mixed Th1/Th2
Route of immunization: IM
Point of Contact: Dennis Carson, UCSD</obo:IAO_0000116>
        <obo:IAO_0000117>Dennis Carson</obo:IAO_0000117>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>2G053</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/649</obo:IAO_0000233>
        <obo:VO_0005328>80</obo:VO_0005328>
        <rdfs:label>2G053 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006099 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006099">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A combination vaccine adjuvant of a synthetic TLR agonist and aluminum salt.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature:
- Synthetic derivative of natural compound
- Combination adjuvant
- Mineral salt
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased
Route of immunization: SQ, IM
Point of Contact: Valerie Soza, Access to Advanced Health Institute (AAHI)
Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=37454145
https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505
https://www.ncbi.nlm.nih.gov/pubmed/?term=28828575
https://www.ncbi.nlm.nih.gov/pubmed/?term=30013570
https://www.ncbi.nlm.nih.gov/pubmed/?term=24211167
https://www.ncbi.nlm.nih.gov/pubmed/?term=23933525
https://www.ncbi.nlm.nih.gov/pubmed/?term=34597297
https://www.ncbi.nlm.nih.gov/pubmed/?term=36996185
https://www.ncbi.nlm.nih.gov/pubmed/?term=28464026
Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT03910972
https://clinicaltrials.gov/ct2/show/NCT02126462
https://clinicaltrials.gov/ct2/show/NCT02839161
https://clinicaltrials.gov/ct2/show/NCT03110757
https://clinicaltrials.gov/ct2/show/NCT02337855
https://clinicaltrials.gov/ct2/show/NCT01717950
https://clinicaltrials.gov/ct2/show/NCT02476773
https://clinicaltrials.gov/ct2/show/NCT01261130
https://clinicaltrials.gov/ct2/show/NCT01385189
https://clinicaltrials.gov/ct2/show/NCT03172975</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>GLA-Alum</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/650</obo:IAO_0000233>
        <obo:VO_0005328>83</obo:VO_0005328>
        <rdfs:label>GLA-Alum vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006100 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006100">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001354"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A combination vaccine adjuvant of a synthetic TLR4 agonist and aluminum salt.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature:
- Synthetic derivative of natural compound
- Combination adjuvant
- Mineral salt
Mechanism of Action: Innate Immune Activation
Immune profile induced: Th1-biased
Route of immunization: IM
Point of Contact: Valerie Soza, Access to Advanced Health Institute (AAHI)
Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=26901122
https://www.ncbi.nlm.nih.gov/pubmed/?term=32983577</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>SLA-Alum</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/651</obo:IAO_0000233>
        <obo:VO_0005328>82</obo:VO_0005328>
        <rdfs:label>SLA-Alum vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006101 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006101">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that includes squalene-based oil-in-water emulsion.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Emulsion
Mechanism of Action: n/a
Immune profile induced: Mixed Th1/Th2
Route of immunization: IM, SQ
Point of Contact: Valerie Soza, Access to Advanced Health Institute (AAHI)
Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=19679214
https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687
https://www.ncbi.nlm.nih.gov/pubmed/?term=28429728
https://www.ncbi.nlm.nih.gov/pubmed/?term=37495191
https://www.ncbi.nlm.nih.gov/pubmed/?term=36256646
https://www.ncbi.nlm.nih.gov/pubmed/?term=28089141
Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT03330899
https://clinicaltrials.gov/ct2/show/NCT01612000
https://clinicaltrials.gov/ct2/show/NCT02464163
https://clinicaltrials.gov/ct2/show/NCT02464163</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Oliver He</obo:IAO_0000117>
        <obo:IAO_0000117>Valerie Soza</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Stable Emulsion (SE)</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/652</obo:IAO_0000233>
        <obo:VO_0005328>84</obo:VO_0005328>
        <rdfs:label>Stable Emulsion (SE) vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006102 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006102">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0006109"/>
        <obo:IAO_0000115>A nucleic acid vaccine adjuvant that is primarily composed of oligonucleotide.</obo:IAO_0000115>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <rdfs:label>oligonucleotide vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006103 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006103">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that is squalene-based adjuvant, induces T follicular helper cells and humoral immune responses via alpha-tocopherol component.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Emulsion
Mechanism of Action: n/a
Immune profile induced: Th1-biased

Route of immunization: IM
Point of Contact: Maki Hayase, Shionogi &amp;Co., Ltd

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=36372670
https://www.ncbi.nlm.nih.gov/pubmed/?term=36891311
https://www.ncbi.nlm.nih.gov/pubmed/?term=36460696
https://www.ncbi.nlm.nih.gov/pubmed/?term=35691872

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT05212948</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Maki Hayase</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000118>A-910823</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:36891311</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/666</obo:IAO_0000233>
        <obo:VO_0005328>90</obo:VO_0005328>
        <rdfs:label>A-910823 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006104 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006104">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0006102"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>An oligonucleotide vaccine adjuvant that is a TLR9-agonistic adjuant containing a CpG oligonucleotide annealed to a complementary strand with an amphiphilic chain unit, acts as a potent cancer vaccine adjuvant by targeting draining lymph nodes.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Oligonucleotide
Mechanism of Action: Activation of TLR9 signaling pathway
Immune profile induced: Th1-biased

Route of immunization: IM, SQ
Point of Contact: Maki Hayase, Shionogi &amp;Co., Ltd

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=35003132
https://www.ncbi.nlm.nih.gov/pubmed/?term=37243234

Ongoing clinical trials:
N/A</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Maki Hayase</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000118>S-540956</obo:IAO_0000118>
        <obo:IAO_0000119>PMID:35003132</obo:IAO_0000119>
        <obo:IAO_0000119>PMID:37243234</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/667</obo:IAO_0000233>
        <obo:VO_0005328>91</obo:VO_0005328>
        <rdfs:label>S-540956 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006105 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006105">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A vaccine adjuvant which is a small molecule adjuvant that is able to induce a mixed Th1/Th2 response and active innate immunity. </obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Small molecule
Mechanism of Action: Activation of innate immunity
Immune profile induced: Mixed Th1/Th2

Route of immunization: IM, ID
Point of Contact: Ofer Levy, Precision Vaccines Program at Boston Children&apos;s Hospital</obo:IAO_0000116>
        <obo:IAO_0000116>It may actually be the world’s first small-molecule TLR3 agonist.</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Ofer Levy</obo:IAO_0000117>
        <obo:IAO_0000118>Precision Vaccines Program (PVP)-057</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/676</obo:IAO_0000233>
        <obo:VO_0005328>86</obo:VO_0005328>
        <rdfs:label>precision vaccines program-057 vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006106 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006106">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001355"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>An emulsion vaccine adjuvant that targets on TLR-agonist. It is a nucleic acid-based adjuvant for chemical nature</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Nucleic acid, Emulsion
Mechanism of Action: Innate Immune Activation, preferential uptake by APCs
Immune profile induced: Th1-biased
Definition: TLR-agonist for target; nucleic acid-based adjuvant for chemical nature

Route of immunization: SQ, IN, IM
Point of Contact: Madhavan Nallani, ACM Biolabs

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=34618423
https://www.ncbi.nlm.nih.gov/pubmed/?term=36223228

Ongoing clinical trials:
https://clinicaltrials.gov/ct2/show/NCT05385991</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Madhavan Nallani</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000118>ACM-CpG</obo:IAO_0000118>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/690</obo:IAO_0000233>
        <obo:VO_0005328>92</obo:VO_0005328>
        <rdfs:label>ACM-CpG vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006107 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006107">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0001356"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0000087"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0000147"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/RO_0001000"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/NCBITaxon_12264"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005309"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A particulate antigen delivery system vaccine adjuvant derived from Cowpea mosaic virus that is able to induce a Th1-biased response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: Nucleoprotein complex
Mechanism of Action: recognized by PRRs
Immune profile induced: Th1-biased

Route of immunization: Intratumoral, intraperitoneally , IV
Point of Contact: Nicole Steinmetz, University of California, San Diego

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=26689376
https://www.ncbi.nlm.nih.gov/pubmed/?term=37844250

Ongoing clinical trials:
none</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nicole Steinmetz</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Wolfgang Leitner</obo:IAO_0000117>
        <obo:IAO_0000118>Cowpea mosaic virus</obo:IAO_0000118>
        <obo:IAO_0000119>Pubmed:26689376</obo:IAO_0000119>
        <obo:IAO_0000119>Pubmed:37844250</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/684</obo:IAO_0000233>
        <obo:VO_0005328>93</obo:VO_0005328>
        <rdfs:label>cowpea mosaic virus vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006108 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006108">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0006109"/>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/VO_0005312"/>
                <owl:someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/VO_0005311"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A nucleic acid vaccine adjuvant that targets on TLR3 agonist to induce a mixed Th1/Th2 response.</obo:IAO_0000115>
        <obo:IAO_0000116>Chemical Nature: dsRNA
Mechanism of Action: TLR3 agonist
Immune profile induced: Mixed Th1/Th2
category: nucleic-acid based adjuvant (TLR-agonist)
synthetic derivative of natural compound
Route of immunization: IM
Point of Contact: Seungbin Cha, NA Vaccine Institute

Pubmed References:
https://www.ncbi.nlm.nih.gov/pubmed/?term=36761735
https://www.ncbi.nlm.nih.gov/pubmed/?term=38136298

Ongoing clinical trials:
none</obo:IAO_0000116>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <obo:IAO_0000117>Nilufer kosar</obo:IAO_0000117>
        <obo:IAO_0000117>Seungbin Cha</obo:IAO_0000117>
        <obo:IAO_0000118>Nexavant</obo:IAO_0000118>
        <obo:IAO_0000119>Pubmed:36761735</obo:IAO_0000119>
        <obo:IAO_0000119>Pubmed:38136298</obo:IAO_0000119>
        <obo:IAO_0000233>https://github.com/vaccineontology/VO/issues/694</obo:IAO_0000233>
        <obo:VO_0005328>94</obo:VO_0005328>
        <rdfs:label>nexavant vaccine adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/VO_0006109 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/VO_0006109">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/VO_0000580"/>
        <obo:IAO_0000115>A vaccine adjuvant that is primarily composed of nucleic acid.</obo:IAO_0000115>
        <obo:IAO_0000117>Jie Zheng</obo:IAO_0000117>
        <rdfs:label>nucleic acid vaccine adjuvant</rdfs:label>
    </owl:Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 4.5.26) https://github.com/owlcs/owlapi -->

